The Impact Of Transcatheter Aortic Valve Implantation (TAVI) On Cognition: Evaluating The Relationship Between Changes In Cognitive Function, Cerebral Injury, Physical Ability, And Mood by Reckow, Jaclyn
University of North Dakota
UND Scholarly Commons
Theses and Dissertations Theses, Dissertations, and Senior Projects
January 2016
The Impact Of Transcatheter Aortic Valve
Implantation (TAVI) On Cognition: Evaluating
The Relationship Between Changes In Cognitive
Function, Cerebral Injury, Physical Ability, And
Mood
Jaclyn Reckow
Follow this and additional works at: https://commons.und.edu/theses
This Dissertation is brought to you for free and open access by the Theses, Dissertations, and Senior Projects at UND Scholarly Commons. It has been
accepted for inclusion in Theses and Dissertations by an authorized administrator of UND Scholarly Commons. For more information, please contact
zeineb.yousif@library.und.edu.
Recommended Citation
Reckow, Jaclyn, "The Impact Of Transcatheter Aortic Valve Implantation (TAVI) On Cognition: Evaluating The Relationship Between
Changes In Cognitive Function, Cerebral Injury, Physical Ability, And Mood" (2016). Theses and Dissertations. 1952.
https://commons.und.edu/theses/1952
	  THE IMPACT OF TRANSCATHETER AORTIC VALVE IMPLANTATION 
(TAVI) ON COGNITION: EVALUATING THE RELATIONSHIP BETWEEN 
CHANGES IN COGNITIVE FUNCTION, CEREBRAL INJURY, PHYSICAL 
ABILITY, AND MOOD 
 
by 
 
Jaclyn Reckow 
Master of Arts, University of North Dakota, 2016 
 
A Dissertation 
Submitted to the Graduate Faculty 
of the 
University of North Dakota 
in partial fulfillment of the requirements 
 
for the degree of 
Doctor of Philosophy 
 
Grand Forks, North Dakota 
August 
2016 
 
	   	  
	  ii 
This dissertation, submitted by Jaclyn Reckow in partial fulfillment of the requirements 
for the Degree of Doctor of Philosophy from the University of North Dakota, has been 
read by the Faculty Advisory Committee under whom the work has been done and is 
hereby approved. 
 
 
 
______________________________ 
Thomas Petros, Ph.D.    
 
______________________________ 
F. Richard Ferraro, Ph.D.   
 
______________________________ 
Joseph Miller, Ph.D.    
 
______________________________ 
Alison Looby, Ph.D.    
 
______________________________ 
Lindsay J. Hines, Ph.D.     
 
______________________________ 
 Christopher Atkinson, Ph.D.  
  
  
 
 
This thesis is being submitted by the appointed advisory committee as having met all of 
the requirements of the Graduate School at the University of North Dakota and is hereby 
approved. 
 
 
 
______________________________ 
Wayne Swisher 
Dean of the School of Graduate Studies 
 
 
______________________________ 
October 23, 2015
	   	  
	  iii 
PERMISSION 
 
 
Title The effects of transcatheter aortic valve implantation (TAVI) on 
cognition: Evaluating the relationship between changes in cognitive 
function, cerebral injury, physical ability, and mood 
 
Department Psychology 
 
Degree  Doctor of Philosophy 
 
 
 
 In presenting this dissertation in partial fulfillment of the requirements for a 
graduate degree from the University of North Dakota, I agree that the library of this 
University shall make it freely available for inspection. I further agree that permission for 
extensive copying for the scholarly purposes may be granted by the professor who 
supervised my dissertation work or, in his absence, by the Chairperson of the department 
or the dean of the School of Graduate Studies. It is understood that any copying or 
publication or other use of this dissertation or part thereof for financial gain shall not be 
allowed without my written permission. It is also understood that due recognition shall be 
given to me and to the University of North Dakota in any scholarly use which may be 
made of any material in my dissertation.  
 
 
 
 
 
 
 Jaclyn Reckow 
 10/23/2015 
 
 
	   	  
	  iv 
 
 
TABLE OF CONTENTS 
 
LIST OF TABLES………………………………………………………………………..vi 
 
ACKNOWLEDGEMENTS……………………………………………………………...vii 
 
ABSTRACT…………………………………………………………………………….viii 
 
CHAPTER 
  
 I.          INTRODUCTION………………………………………………….……..1 
Cardiovascular Disease and Cognition……………………………1 
Cardiovascular Disease Treatment and Cognition………………...3 
TAVI Procedure and Cerebral Injury……………………………..4 
Cerebral Ischemia and Cognitive Function……………………….8 
TAVI, Cerebral Injury, and Cognition…………………………...12 
TAVI and Quality of Life………………………………………..20 
 Activities of Daily Living………………………………..20 
 Quality of Life……………………………………………20 
 Mood……………………………………………………..21 
 Frailty…………………………………………………….22 
Present Study…………………………………………………….24 
 II. METHOD………………………………………………………………..26 
 
   Participants………………………………………………………26 
 
   Cognitive Evaluation…………………………………………….27
	   	  
	  v 
   Cognitive Assessment Materials…………………………………28 
 
    Repeatable Battery for the Assessment for    
    Neuropsychological Status……………………………….28 
 
    Mini-Mental State Examination………………………….30 
 
    Stroop Color-Word Interference Test……………………31 
 
    Test of Premorbid Function…………………………...…32 
   
    Trail Making Test A and B………………………………32 
 
    Letter Fluency……………………………………………33 
       
    Verbal Series Attention Test……………………………..33 
     
    WAIS-IV Digit Span Subtest…………………………….33 
 
    Geriatric Depression Scale……………………………….34 
 
    Informant Questionnaires………………………………...34 
 
Frailty Measures………………………………………………….34 
Magnetic Resonance Imaging……………………………………34 
Medical Variables………………………………………………..35 
 III.  RESULTS………………………………………………………………..37 
   
   Data Screening…………………………………………………...37 
 
   Patient Characteristics…………………………………………....39 
 
   Procedural Characteristics……………………………………….40 
 
   Cognitive Assessment……………………………………………41 
    
 Mood, Quality of Life, and Frailty Assessment…………………46 
 
   Neuroimaging and Cognitive Performance……………………..47 
 
 IV.  DISCUSSION…………………………………………………………...50 
   Limitations………………………………………………………58 
	   	  
	  vi 
   Future Directions………………………………………………...59  
REFERENCES…………………………………………………………………………..61
	   	  
	  vii 
LIST OF TABLES 
 
Table         Page 
 
1. Medical Variable and Associated Risks for Neurological Injury or Death…………..7 
 
2.  Sample Baseline Characteristics……………………………………………………39 
 
3.  TAVI Procedural Data………………………………………………………………40 
 
4.  RBANS Dependent t-tests Comparing Baseline and One Month Post-TAVI……...42 
 
5.  Dependent t-tests Comparing Baseline and One Month Post-TAVI on          
Cognitive Measures…………………………………………………………………43 
 
6.  Regression Coefficients for Model Predicting Change in RBANS Total Index    
Score………………………………………………………………………………...45 
 
7.  Dependent t-tests Comparing Baseline and One Month Post-TAVI on Quality         
of Life Measures…………………………………………………………………….46 
 
8.  Summary of Group Data for Participants Meeting Frailty Criteria…………………47 
 
9.  Characteristics of Participants with New Ischemia Evidenced on MRI at One   
Month……………………………………………………………………………….48 
 
10.  Wilcoxon Signed Rank Tests Results in Participants (n = 6) with New           
Ischemic Lesions……………………………………………………………………49 
 
 
 
	   	  
	  viii 
ACKNOWLEDGEMENTS 
 
 I wish to express my sincere appreciation to the members of my advisory 
committee for their guidance and support during my time in the Clinical Psychology 
doctoral program at the University of North Dakota. Drs. Petros and Ferraro, who co-
advised me through the years, have offered much-needed words of encouragement and 
were occasionally the thorn in my side; I cannot thank you enough. I would like express 
my sincerest gratitude for Lindsay Hines, Ph.D. and Thomas Haldis, D.O., whose 
characteristic curiosity and complementary knowledge sparked the idea for this project, 
and with hours of guidance and support it blossomed into my dissertation project. I am 
greatly indebted to the Sanford Research Department, particularly Patricia Skarloken and 
Natalie Spitzer, for their dedication to research, their positive and helpful attitude, and 
their unparalleled organizational skills. Thanks also to Rishi Seth, MD who spent hours 
in front of the computer screen patiently explaining medical terminology to me and 
helping to close the gap between disciplines. My dissertation would not have been 
possible without hours of help from many research assistants; I wish you all the best in 
your futures. Finally, I am grateful to my family and friends, always just a phone call or 
coffee break away, who provided balance to my life; Abraham Bilyeu, Ph.D. was there 
from proposal to defense, and his empathy and support has been invaluable. 
	   	  
	  ix 
ABSTRACT 
 Aortic stenosis is a cardiovascular disease affecting 2 to 4% of U.S. adults over 
age 65 years old (Freeman & Otto, 2006). Aortic stenosis causes angina and syncope 
eventually leading to heart failure and death (Otto, 2006). Transcatheter aortic valve 
implantation (TAVI) is an alternative to surgical aortic valve replacement in patients with 
high surgical mortality risk (Kappetein, 2013). The TAVI is associated with increased 
cerebral injury, with silent ischemia reported in up to 90% of TAVI patients (Samim et 
al., 2015). The present study examines the relationship between cerebral injury, cognitive 
changes, and quality of life in TAVI patients.  
 Participants (n = 40) completed a cognitive assessment one day before the TAVI 
and at one-month post-TAVI. The primary cognitive measure was the Repeatable Battery 
for the Assessment of Neuropsychological Status (RBANS). Additional tests (letter 
fluency, Trail Making Test, Digit Span Backward and Stroop) were included as measures 
of executive function and working memory. Measures of functional ability (Physical 
Self-Maintenance Questionnaire, Functional Activities Questionnaire, Dementia Severity 
Rating Scale), mood (GDS), and quality of life (Kansas City Cardiomyopathy 
Questionnaire) were also included. Baseline and follow-up MRIs were completed for 22 
participants. Baseline RBANS Total Index scores (M = 85.26, SD = 14.69) evidenced 
mild cognitive decline prior to the TAVI. At one month, there was significant 
improvement on RBANS Language Index (p = 0.014), RBANS Fluency (p = 0.023), 
RBANS Figure Recall (p = 0.027), GDS (p = 0.018), and KCCQ (p < 0.001). There was a 
	   	  
	  x 
significant decline on RBANS List Recall (p = 0.001). Six participants (27%) obtained 
new cerebral lesions at one month. Participants with neuronal injury did not differ from 
those without at one month (RBANS Total Score, p = 0.45).  
 TAVI is related to overall stable cognitive performance and improved quality of 
life. The relationship between cerebral ischemia following TAVI and negative cognitive 
consequences is not supported. Further research is required in the cognitive implications 
following TAVI.
	   	  
	  1 
CHAPTER I 
INTRODUCTION 
Cardiovascular Disease and Cognition 
 The relationship between cardiovascular disease and cognitive function is well 
established in previous literature (Katzel & Waldstein, 2001). Cardiovascular disease 
(CVD) is a broad term encompassing diseases of the heart, blood vessels, and circulation 
(Katzel & Waldstein, 2001). CVD accounts for the most deaths in the United States per 
year than any other cause. Stroke, often resulting from CVD, is the third highest cause of 
death in the United States (Katzel & Waldstein, 2001).  
 CVD is related to cognitive decline in older adults (Katzel & Waldstein, 2001). 
For example, hypertension, a predecessor to more serious CVDs, has been shown to 
negatively affect cognitive function. Hypertension (i.e., systolic blood pressure ≥140 
millimeters of mercury (mmHg) and/or diastolic blood pressure ≥90 mmHg) is a risk 
factor for coronary artery disease, and atherogenesis (i.e., the deposit of plaque 
particularly on the inner arterial wall) (Waldstein & Katzel, 2001). Longitudinal studies 
have found that long-term hypertension is related to poorer performance on attention and 
memory tasks in older adults, and hypertension predicts decline on Wechsler Adult 
Intelligence Scale visuospatial subtests (Picture Completion, Picture Arrangement, Block
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 Design, and Object Assembly) and speed subtests (Digit Symbol Substitution) (Elias 
Robbins, Elias, & Streeten, 1998). Additional longitudinal studies show that midlife 
hypertension predicted decline on tests of mental status and cognitive flexibility 
(Waldstein & Katzel, 2001). The relationship between CVD and cognitive decline may 
also have bidirectional negative consequences. Cognitive decline is a predictor of all 
cause mortality after hospitalization in adults greater than 70 years old with 
cardiovascular disease (Farid et al., 2013). 
 Atherosclerosis is arterial narrowing caused by the accumulation of fatty deposits 
and fibrous tissue in the vessel wall (Everson, Helkala, Kaplan, & Salonen, 2001). 
Fibrous plaques may become calcified, which decreases vessel flexibility and increases 
frailty. Severe complications as a result of atherosclerosis include stroke, ischemia (i.e., 
areas of restricted blood flow), and heart attack. Carotid atherosclerosis has been shown 
to result in poorer cognitive functioning in global cognition, nonverbal memory, 
cognitive flexibility, verbal fluency, and verbal memory (Everson, Helkala, Kaplan, & 
Salonen, 2001).  
 Hypoperfusion–lack of adequate blood flow and oxygen to the brain–is often 
cited as the causal link between CVD and decreased cognitive abilities (Jefferson, 
Poppas, Paul, & Cohen, 2007). Jefferson and colleagues (2007) examined the relationship 
between neuropsychological functioning and cardiac output. Seventy-two participants 
(mean age = 69.14) completed a neuropsychological battery and an echocardiogram. Data 
from the echocardiogram was used to estimate cardiac output, which is the amount of 
blood pumped from the heart to the systemic vascular system per minute (Jefferson et al., 
2007). When the participants were grouped based on cardiac output (low versus normal), 
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the low cardiac output group performed worse on executive measures (DKEFS Tower 
Test and DKEFS Trail Making Test) (Jefferson et al., 2007). Increased cerebral perfusion 
following stenting in the carotid artery significantly predicts cognitive improvement 
based on the informant behavioral observations in the Informant Questionnaire on the 
Cognitive Decline in the Elderly (IQ-CODE; Moftakhar, Turk, Niemann, et al., 2005). 
The IQ-CODE has been shown to correlate with Mini-Mental State examination and 
episodic memory (Moftakhar et al., 2005). 
Cardiovascular Disease Treatment and Cognition 
 In addition to CVD alone, treatment of CVD may have cognitive implications. 
Coronary artery bypass grafting (CABG) is a surgical procedure to treat coronary artery 
disease (CAD), which is caused by progressive narrowing to eventual occlusion in the 
coronary arteries by artherosclerotic plaque (Newman, Stygall, & Kong, 2001). Studies 
have found neuropsychological deficits following CABG in the following cognitive 
domains: memory, attention, visuospatial, language, visuomotor, executive function, and 
global functioning (Newman, Stygall & Kong, 2001). Cognitive changes following 
CABG are often inconsistent with each study showing decline in different cognitive 
domains, and these discrepancies are likely due to differing methodologies. Studies with 
post testing evaluations within days following the surgery may be measuring 
confounding factors such as postoperative recovery from anesthesia and surgery 
(Newman, Stygall & Kong, 2001). Mahanna et al. (1996) assessed cognitive functioning 
in 232 coronary artery bypass patients 6 days post-surgery and found decline (i.e., a 
decrease of 20% from baseline on at least 20% of the measures) in 66% of patients. In the 
same study, 34% continued to show cognitive impairment at 6 weeks and 19.4% 
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continued at the 6-month follow-up.  Studies with postoperative evaluations weeks or 
months following the procedure measure more stable neuropsychological decline. For 
example, Sellman, Holm, Ivert, and Semb (1993) assessed cognitive functioning 4 weeks 
post-surgery in 54 coronary artery bypass surgery patients, and the researchers found 
cognitive decline in 17% of the patients. In the same study, cognitive decline was stable 
for 7% of the patients at a 6-month follow-up. Even with similar methodologies and 
testing intervals, results are still variable in studies examining neuropsychological 
functioning after cardiac surgery. However, research indicates that risk factors for 
postoperative decline following CABG include increased age, female gender, and 
increased severity of cardiac disease (Newman, Stygall, & Kong, 2001). 
TAVI Procedure and Cerebral Injury 
 One type of CVD in the older adult population is aortic stenosis. Aortic stenosis is 
narrowing of the aortic valve, which is located between the heart's left ventricle and the 
aorta, and may result in backed up blood flow and increased pressure in the heart (Otto, 
2006). Aortic stenosis results from a disease process of lipid accumulation, inflammation, 
and calcification (Otto, 2006). Aortic sclerosis (i.e., thickening and hardening of the 
aortic valve and precursor to stenosis) is found in approximately 2% of people age 65-74 
years and approximately 48% in people over 84 years old (Freeman & Otto, 2005). The 
risk of developing aortic stenosis increases with age with 2-4% of adults over the age of 
65 meeting diagnostic criteria (Freeman & Otto, 2005). The disease ranges in severity, 
but those with severe symptomatic aortic stenosis experience angina (i.e., chest pain), 
syncope (i.e., fainting resulting from a fall in blood pressure), and heart failure (Otto, 
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2006). Aortic stenosis is typically treated through surgical aortic valve replacement (open 
heart surgery).  
 Transcatheter aortic valve implantation (TAVI) is a recently-developed procedure 
to treat high-grade aortic stenosis in patients with risk factors that preclude the patients 
from conventional aortic valve replacement (AVR) surgery. To qualify for TAVI, 
patients must be denied surgical aortic valve replacement by two independent surgeons 
based on mortality risk (Kappetein et al., 2013). The European System for Cardiac 
Operative Risk Evaluation (EuroSCORE) and/or The Society for Thoracic Surgeons' risk 
score (STS score) are used as assessments to evaluate patient mortality risk prior to the 
procedure. The EuroSCORE includes patient factors (e.g., age, sex, history of chronic 
pulmonary diseases, etc.), cardiac factors (e.g., unstable angina, recent myocardial 
infarct, etc), and operation factors (e.g., level of emergency, additional cardiac 
procedures performed in conjunction, etc.). A high mortality risk as assessed by the 
EuroSCORE and other risk factors including liver disease, frailty, and severe pulmonary 
hypertension (Kappetein et al., 2013) are combined with the cardiac surgeon's clinical 
judgment to decide the patient's candidacy for surgical AVR.  The STS score contains 
multiple risk factors including, but not limited to morbid obesity, prior cardiac 
conditions, medical conditions (e.g., diabetes, chronic pulmonary obstructive disease, 
etc.), and type of procedure to predict mortality (Collas, Chong, Rodrigus, Vandewoude, 
& Bosmans, 2015). Predicting mortality for TAVI patients is difficult, and the STS-score 
is slightly more accurate in predicting two year mortality in high-risk patients than the 
EuroSCORE (Collas et al., 2015).  
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 TAVI clinical trials have shown promising results in long-term success with 
patients (Ussia, Barbanti, Petronio, et al., 2012; Toggweiler et al., 2013). However, 
compared to AVR, TAVI is associated with higher rates of clinically significant stroke 
(i.e., cerebral injury that results in overt changes in neurological function) (Hauville, Ben-
Dor, Lindsay, Pichard, & Waksman, 2012). Studies examining neurological injury 
following cardiac procedures show clinically significant stroke following AVR ranges 
from 0.7% to 5% while stroke following the TAVI procedure ranges from 0% to 10% 
(Hauville et al., 2012).  
 Neurological injury (i.e., any number of central nervous system (CNS) injuries, 
including encephalopathy, stroke, coma, delirium, and neurocognitive decline) is a 
common concern following any cardiac surgery, particularly in older adults with 
comorbid risk factors (Newman et al., 2006). TAVI candidates are typically older adults 
with multiple risk factors, which resulted in their ineligibility for AVR. Even mild CNS 
injury following cardiac surgery relates to decreased quality of life and cognitive abilities 
(Newman et al., 2001), and it is associated with increased medical costs (Roach et al., 
1996). Previous research identifies a number of risk factors associated with increased 
major stroke, higher rates of major cardiac or cerebral events, and mortality in TAVI 
patients. See Table 1 for a list of medical variables that previous studies have associated 
with CNS injury and cardiac surgery/TAVI. 
 The increased neurologic injury from TAVI has been associated with increased 
emboli from the procedure (Arnold et al., 2010). Emboli may include air bubbles, fatty 
deposits, blood clots, or another object that causes blood flow obstruction.  In addition to 
clinically significant stroke (see above), TAVI may have increased rates of clinically  
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Table 1.  
 
Medical variables and associated risks for neurological injury or death 
Variable Associated Risk Reference 
 
Age 
Unstable angina 
Diabetes (type I or II and insulin use) 
History of neurological disease 
Previous coronary artery bypass 
surgery 
History of vascular disease, history 
of Pulmonary disease 
 
 
Stroke following cardiac 
surgery 
 
Newman et al. 
2006 
Atrial Fibrillation Stroke and Transient 
Ischemic Attacks 
following cardiac surgery 
 
Creswell, 1999 
 
Cerebrovascular disease  
History of coronary artery disease 
Higher transvalvular aortic gradient 
Gender (male)  
Hyperlipidemia  
Renal dysfunction  
Porcelain aorta  
Increased left atrial appendage 
velocity Lower aortic atheroma 
thickness 
Reduced aortic valve area 
 
Silent Ischemia following 
TAVI 
Kahlert et al., 2010 
Rodes-Cabau et al., 
2011 
Tay et al., 2011 
Increased creatine levels 
Higher EuroSCORE 
 
Mortality following TAVI Codner et al., 2013 
 
Left ventricular function (ejection 
fraction <30%) 
Moderate/severe aortic regurgitation 
History of COPD 
Mortality following TAVI Moat et al., 2011 
 
 
silent cerebral injury. Cerebral injuries that occur in the absence of specific neurological 
dysfunction are considered clinically silent; clinically-silent cerebral injuries are only 
detected through neuroimaging (Hauville et al, 2012). Neuroimaging techniques identify 
areas of restricted blood flow known as ischemia. Persistent ischemia may lead to 
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infarcts, which are permanent areas of dead tissue in the brain. Both ischemia and infarcts 
can be clinically-apparent and clinically-silent cerebral injuries depending on the location 
of the lesion.  
 Diffusion-weighted magnetic resonance imaging (DW-MRI) is an imaging 
technique that is more sensitive to detecting ischemia than the standard MRI (Hauville et 
al, 2012).  The relationship between detected ischemia and true neuronal damage is 
unclear (Bendszus & Stoll, 2006). Some studies have shown initial ischemic lesions 
persisted to structural damage at later testing times while other studies have shown 
lesions on DW-MRI cease without neuronal damage due to resolution of the restricted 
blood flow. The discrepancies in results are likely due to different times the imaging was 
completed. Overall, ischemia on DW-MRI that is present more than 24 hours after the 
initial event are indicative of cerebral infarction (i.e., tissue death due to obstructed blood 
supply) (Bendszus & Stoll, 2006). 
Cerebral Ischemia and Cognitive Function 
 Studies examining the relationship between silent cerebral ischemia and cognitive 
functioning have shown small or no effects (Bendszus & Stoll, 2006). Many studies only 
include measures of global cognitive function (i.e., Mini-Mental State Examination) as 
measurements of cognitive deficit and more nuanced changes in cognitive areas such as 
processing speed and mood may be missed (Bendszus & Stoll, 2006).  
 Studies including more comprehensive cognitive measures show mixed results for 
effects of lesions detected on DW-MRI. Knipp et al. (2005) administered a 
neuropsychological battery assessing seven cognitive domains to 39 coronary artery 
bypass graft surgery patients at baseline, at discharge, and at a three-month follow-up. At 
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discharge, patients exhibited cognitive decline in all domains compared to pretest 
performance. At the 3 month follow-up cognitive function was regained in all domains, 
except immediate recall during a verbal learning task, which remained significantly 
below baseline. Twenty patients (51%) evidenced new ischemic lesions following the 
procedure. Those with ischemia were no more likely to have persistent cognitive decline 
at the 3-month follow-up than patients without new lesions (n = 19). The ischemic injury 
did not account for the cognitive decline in the study's sample.  
 Conversely, Restrepo et al. (2002) found that patients with new lesions on DW-
MRI had significantly larger declines on neuropsychological tests of psychomotor speed, 
language, and visuospatial abilities than patients without new lesions. Restrepo et al. 
(2002) used pre and post-neuroimaging and cognitive assessment in patients undergoing 
coronary artery bypass grafting surgery. The cognitive assessment was completed within 
a week prior to the procedure and within a week after the procedure. The assessment 
included trail making test B (processing speed), oral and written naming tests, oral 
reading tests (language), line cancellation, and Bells tests (visuospatial). Thirteen patients 
completed both the pre and postoperative assessments. Ten patients experienced 
cognitive decline in at least one test (7 demonstrated decline on one test, 2 patients 
showed decline in >1 test, and 1 patient showed decline on 5 tests). Four patients showed 
new diffusion lesions in the postoperative neuroimages, and patients with new lesions on 
DW-MRI had greater decline (i.e., larger z-score change) between pre and postoperative 
cognitive assessments than patients without new lesions (Restrepo et al., 2002). In 
comparison to Knipp et al. (2005), the time of post-procedural cognitive evaluations may 
explain the discrepancy in results. Restrepo et al. (2002) completed the follow-up 
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cognitive evaluation within one week following the procedure while Knipp et al. (2005) 
had a 3-month follow-up examination. Ischemic lesions may relate to cognitive decline 
shortly following the cardiac procedure (as found in Restrepo et al., 2002), but the 
cognitive impact of ischemic lesions could be reduced over time (as found in Knipp et al., 
2005). Additionally, surgical effects such as recovery from anesthesia may confound 
cognitive testing within days following a surgical procedure (Newman, Stygall & Kong, 
2001). Ischemic lesions are only one factor to consider when examining cognitive 
performance following a cardiac procedure. 
 In patients undergoing a coronary artery bypass grafting (CABG) with on-pump 
procedure (i.e., a heart-lung artificial circulation system is used and the heart is stopped), 
ischemic lesions were associated with cognitive dysfunction (Lund et al., 2005). 
However, ischemic changes were not associated with cognitive decline in patients 
undergoing the procedure off-pump (i.e., the heart continues beating) (Lund et al., 2005). 
One hundred six patients were given a neuropsychological evaluation preoperatively, at a 
3-month follow-up, and at a 1-year follow-up. Patients were given 10 tests measuring six 
cognitive domains: Grooved pegboard (motor coordination), Digit Symbol, Trail Making 
Test (psychomotor speed), Digit Span, Stroop Color-Word Interference Test (attention), 
Rey Auditory Verbal Learning, Rey Auditory Verbal Learning Recall (verbal memory), 
Similarities, Controlled Oral Word Association Test (verbal comprehension and fluency), 
Block Design (visuoconstructive abilities). Eleven of the 54 off-pump patients and 12 of 
52 on-pump patients demonstrated cognitive decline at 3 months (Lund et al., 2005). 
After one year, 13 of the 54 off-pump and 12 of the 52 on-pump patients had continued 
cognitive impairment. Neuroimaging revealed new ischemic lesions in 13 (12.5%; 9 on-
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pump; 4 off-pump) of the patients. New ischemic changes were not associated with 
cognitive decline in either group, but preoperative MRI classification (i.e., normal, 
borderline, pathologic) was significantly correlated with cognitive decline for the on-
pump patients. Preoperative MRI classifications were normal when no cerebral lesions 
were present, borderline when cerebral lesions were < 5mm, and pathologic when 
cerebral lesions were >5mm. No patients with normal preoperative MRI had cognitive 
impairment at 3 months. Twenty percent of patients with borderline preoperative MRI 
and 27.1% with pathologic preoperative MRI had cognitive decline at 3 months (Lund et 
al., 2005). The authors state that prior cerebral lesions may result in fewer cognitive 
resources and a greater susceptibility to negative consequences from ischemia occurring 
from the procedure. 
 In another study using coronary artery bypass grafting (CABG) patients, new 
ischemic lesions were not associated with postoperative cognitive decline (Bendszus et 
al., 2002). Bendszus and colleagues (2002) administered the d2-letter cancellation test 
(sustained attention and concentration), Benton Visual retention test (visual short-term 
memory and visuomotor), Reitan trail-making test A (attention, psychomotor tracking 
speed, and motor coordination) at 2 days pre-procedure and 3, 6, and 9 days post-surgery. 
Nine of 35 patients (26%) exhibited new ischemic lesions following CABG. Patients with 
prior diffuse white matter changes noted in the preprocedural MRI were more likely to 
experience new ischemic lesions. There was no relationship between new lesions and 
neuropsychological test performance at the 3-day follow-up (Bendszus et al., 2002). 
Instead of new ischemic lesions, overall neuronal loss (combined pre- and post-CABG 
neuronal damage) may account for cognitive changes. The researchers used the 
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biomarker N-Acetylaspartate to indirectly measure neuronal injury. N-Acetylaspartate is 
found exclusively in neuronal tissue, and decreased levels are associated with neuronal 
loss or impaired functioning in neurons. The authors found decreased N-Acetylaspartate-
creatine ratios were associated with decreased performance on the letter cancellation test, 
Reitan Trail Making A, and Benton visual retention tasks 3 days postprecedure 
(Bendszus et al., 2002). When the N-Acetylaspartate-creatine levels returned to baseline 
10-14 days postoperatively, neuropsychological functioning also returned to baseline. 
TAVI, Cerebral Injury, and Cognition  
 Understanding the cognitive impact of silent ischemia is an important aspect in 
the TAVI procedure as TAVI patients have a high occurrence of ischemia. DW-MRI 
studies have found silent ischemic changes in 68% to 90% of TAVI patients, but many 
studies have not extensively examined cognitive sequelae from these ischemic changes 
(Rodes-Cabau, Dumont, Boone et al., 2011; Kahlert et al., 2010; Samim et al., 2015). 
Compared to the standard surgical AVR, the TAVI procedure is associated with higher 
occurrence of lesions detected by DW-MRI. The observed DW-MRI lesion rate for 
surgical AVR ranges from 38% to 47% (Spaziano et al., 2014). 
 Rodes-Cabau and colleagues (2011) examined the difference in cerebral injury in 
patients following transapical (TA) TAVI (n = 31) and transfemoral (TF) TAVI (n = 29) 
procedures. TA-TAVI and TF-TAVI differ in the artery routes taken to access the aortic 
valve.  TF-TAVI is a more commonly used TAVI approach, in which a valve-containing 
catheter is advanced through the femoral artery and through the aortic arch.  The TA-
TAVI procedure is used for patients with calcified, diseased, or too small arteries, and 
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consists of avoiding the aortic arch by advancing the catheter through the ventricular 
apex located at the bottom of the ventricle, inferior to the aortic valve. 
 DW-MRIs were obtained within 24 hours prior to the TAVI procedure and within 
6 days following the procedure (Rodes-Cabau et al., 2011). Sixty patients completed the 
Mini-Mental State Examination (MMSE) and the National Institutes of Health Stroke 
Scale (NIHSS). The MMSE is a brief global cognitive function screening that measures 
several cognitive areas: orientation to place and time, memory registration, attention, 
memory recall, language, complex commands, and visuospatial ability (Folstein, Folstein, 
& McHugh, 1975). The NIHSS is a 15-item scale measuring neurological functioning 
including vision, gaze, level of consciousness, language, sensory loss, dysarthria, facial 
palsy, extreme weakness, and ataxia (Brott et al., 1989). Pre-procedural DW-MRI results 
indicated that prior to the procedure, no previous acute ischemic lesions were found, and 
old silent ischemic lesions were found in 53% of the patients (Rodes-Cabau et al., 2011). 
Post-procedure imaging results revealed 68% of patients had new ischemic lesions, and 
most patients with new lesions had multiple lesions sites. The new lesions occurred in 
both hemispheres (73%) and in anterior and posterior vascular territories (66%). There 
were no differences between the TA and TF in number or location of new ischemic 
lesions. New lesions were found more frequently in patients that had a history of 
coronary artery disease, that exhibited a higher transvalvular aortic gradient (pressure 
gradient surrounding the aortic valve), and that were male. There were no significant 
differences in neurological function as assessed by the NIHSS between pre- and post-
procedure evaluations for both patients with ischemic lesions and those without. No 
significant differences were found in cognitive function at baseline (MMSE median = 28, 
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range 16-30) compared to after the procedure (MMSE median = 28, range 17-30, p = 
0.14). No differences in cognitive function were found between patients without new 
lesions compared to those with new lesions (p = 0.90) (Rodes-Cabau et al., 2011). 
 Compared to Rodes-Cabau et al. (2011) who found 68% of TAVI patients had 
new ischemic diffusions on DW-MRI, Kahlert et al. (2010) found 86% of TAVI patients 
had new ischemic lesions. Kahlert and colleagues (2010) compared imaging and 
neurological function of patients undergoing a transfemoral TAVI procedure to surgical 
aortic valve replacement. Neurological function was evaluated using the NIHSS, and 
cognitive function was assessed with the MMSE at baseline and post-procedure (2.5 to 
4.4 days). No statistically significance differences were found between baseline MMSE 
(M = 28.4, range = 27.4 to 29.3) and post-procedure MMSE (M  = 28.2, range = 27.3 to 
29.1). No significant changes occurred in NIHSS scores between pre and postoperative 
measurements. Restricted diffusions were found in 86% (19 of 22) of TAVI patients and 
80% of surgical aortic valve replacement (8 of 10) patients. A three-month follow-up 
DW-MRI showed no new restricted diffusion foci beyond lesions initially detected at the 
postoperative evaluation. Additionally, at the three-month follow-up, NIHSS and MMSE 
scores remained similar to baseline. Patient risk factors for new foci included 
hyperlipidemia, renal dysfunction, porcelain aorta, increased left atrial appendage 
velocity, lower aortic atheroma thickness, and reduced aortic valve area at baseline 
(Kahlert et al., 2010).  
 Arnold and colleagues (2010) examined silent ischemia following TA-TAVI 
procedures. Twenty-five patients completed the pre (6±12 days before) and post 
procedural (6±2 days after) MRI examinations. Seventeen (68%) of the patients showed 
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new focal diffusion abnormalities. Five of the 17 with new lesions exhibited neurological 
changes caused by new lesions (Arnold et al., 2010). Neurological changes included 
reduced awareness (one patient), transitive diplopia (one patient), and transitive psychosis 
(three patients) (Arnold et al., 2010). Cognitive function was not assessed in the study. In 
a more recent study, ischemic lesions were found in 90% of patients five days post-TAVI 
(Samim et al., 2015). Significant predictors for new ischemia were age, hyperlipdemia, 
and dilation of the implant. Samim and colleagues (2015) did not examine cognitive 
changes. 
  Another study found few negative neurological effects immediately following and 
at a long-term follow-up after a TF-TAVI procedure (Ghanem et al., 2010). Patients 
completed pre and two post-procedural DW-MRI examinations. The second examination 
occurred 2.2 ± 0.4, and the third examination occurred 91 ± 5 days after the TAVI 
procedure. Sixteen patients (72.7%) showed new ischemic lesions, of which, only three 
patients had ischemia at the second examination that persisted to focal infracted brain 
tissue at the third examination. Only one patient had persistent neurological deficits at the 
third examination (NIHSS = 16). Two patients exhibited neurological deficits at the 
second examination, but not the third examination. These transient neurological 
symptoms were not correlated with DW-MRI lesions (Ghanem et al., 2010). 
 The above research indicates that silent ischemia from the TAVI procedure may 
not have a negative impact on neurological function (i.e., as assessed by the NIHSS) and 
global cognitive function (i.e., as assessed by the MMSE). Overall, the majority of TAVI 
patients experience embolic ischemia following the procedure; however, follow-up 
imaging has shown many lesions resolve (Ghanem, et al, 2010). To date, few studies 
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have used more comprehensive cognitive measures in TAVI patients than the studies 
reported above.  
 Knipp et al. (2013) compared postoperative cognitive function after surgical 
aortic valve replacement (AVR) or transapical aortic valve implantation (TA-TAVI). 
Comparisons between AVR and TAVI are appropriate because TAVI is a nonstandard 
procedure used instead of AVR. However, direct comparison between the groups is 
inherently flawed as the TAVI patients are typically older and have a higher mortality 
risk than AVR patients. Knipp and colleagues, administered different cognitive batteries 
to the AVR and TAVI groups, and only a comparison of general pre to post test patterns 
can be noted.  TAVI participants completed the MMSE as a measure of global cognitive 
function, and the researchers gave measures of verbal short-term memory, verbal 
working memory, verbal learning and delayed recognition, and verbal fluency at baseline 
(5.4 ± 8.1 days before the procedure), post-operative (10.7 ± 4.9 days after the 
intervention), and 3-month (115.6 ± 49.7 days after the intervention) follow-up 
examinations (Knipp et al., 2013). Patients in the TA-TAVI group were significantly 
older and had higher estimated operative risks than the AVR group. In the TA-TAVI 
group (n = 27), no significant cognitive changes were found between baseline and post-
operative examinations. There was a significant increase (p < .05) in MMSE scores and 
digit span backward scores in the TA-TAVI group between the post-operative and 3-
month follow-up evaluations. In the AVR group (n = 37), several cognitive domains (rate 
of information processing, cognitive flexibility, attention, delayed recognition, verbal 
working memory, visual short-term memory, and logical thinking) showed a significant 
decline in performance (p <.05) between pre-operative and post-operative (10.7 ± 4.9 
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days after) examinations. All domains with initial decline postoperatively returned to 
baseline at 3-month follow-up with the exception of cognitive flexibility and logical 
reasoning. Cognitive flexibility and logical reasoning significantly improved from 
baseline to the 3-month follow-up (p < .05) (Knipp et al., 2013).   
 Fifty-eight percent of the TA-TAVI patients and 34% of the AVR group 
evidenced new ischemic lesions on neuroimaging (Knipp et al, 2012). In both the TA-
TAVI and the AVR groups, new ischemia was not indicative of cognitive dysfunction (p 
= 0.66). These results support previous studies, in which cognitive function in the AVR 
group shows decline at the postoperative evaluation, but overall regain of cognitive 
function with some improvement at the 3-month follow-up. Unlike the AVR group, the 
TA-TAVI group failed to show any significant decline on cognitive measures. The TA-
TAVI group had a significant improvement in global cognitive function (MMSE) and 
verbal working memory (Digit span backward) between the postoperative and follow-up 
evaluations; however, the 3 month performance was not significantly different from 
baseline.  
 Ghanem et al. (2013) had 111 TAVI patients complete cognitive testing (RBANS) 
before the procedure, 3 days post, 3 months post, 1 year post, and 2 years post-TAVI. 
Ghanem and colleagues (2013) also had 56 participants complete MRI protocol pre and 3 
days post TAVI. Thirty participants (53.5%) evidenced new embolic events three days 
following the TAVI. Participants with new embolic events did not differ from those 
without embolic events in their cognitive trajectories. Despite new embolic injury, 
cognitive performance remained relatively stable. Ghanem and colleagues examined 
variables to predict postoperative cognitive decline (POCD), as defined as a significant 
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decrease in RBANS standard score following the TAVI. Ghanem and colleagues (2013) 
had only 6 participants show decline. T-tests of variables between those without POCD 
(n = 105) and those with POCD (n = 6) revealed terminal renal failure requiring 
hemodialysis and procedure length were significantly different between the groups. 
Procedure length is used as an indirect measure of the operation complexity (Ghanem et 
al., 2013).  
 Participants had an overall improvement in RBANS total score at the 3 days and 
2-year follow-up compared to baseline (Ghanem et al., 2013). The researchers did not 
discuss the transient improvement at 3 days or later improvement at the 2-year follow-up, 
because the improvements were stated as not clinically significant. Significant 
improvements were also found on the RBANS Immediate Memory subtest at 3 days post-
TAVI and on the RBANS Language subtest at 3 months. A significant decline was 
observed on the RBANS Visuospatial/Constructional subtest at one year. The RBANS 
subtest significant changes were transient and the scores remained or returned to baseline 
at all other follow-ups (Ghanem et al., 2013). Within the 111 participants, the researchers 
found a subset (n =30, 27%) that met criteria for Mild Cognitive Impairment (MCI; as 
defined as >1.5 SD below expected score on their preprocedural RBANS; Ghanem et al, 
2013). The cognitive trajectory of participants with MCI did not differ from those without 
MCI, and participants with MCI even showed transient improvement in cognition 
(Ghanem et al., 2013).  
 Alassar et al. (2015) compared microembolism and cognitive performance in 
TAVI to surgical AVR. Eighty-five TAVI and 42 surgical AVR patients completed DW-
MRI at baseline, 6 days, and 3 months postprocedure. Participants also completed a 
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neurocognitive assessment at baseline and at the 3-month follow-up. The neurocognitive 
assessment consisted of the following measures: Memory score (complex figure test, 
auditory verbal learning test), Executive functioning score (trail making test A and B, 
verbal fluency test), Processing speed (symbol digit replacement, letter cancellation test, 
grooved pegboard test), and Overall cognitive score (an average of the above measures). 
The TAVI participants had significantly lower scores on the Memory index than AVR 
participants at baseline with no other significant differences between the groups. At the 3-
month follow-up (TAVI n = 71, AVR n = 36), overall cognitive function significantly 
improved in both the TAVI and AVR groups, and the change was significantly larger for 
the AVR group than the TAVI group (Alassar et al., 2015). The AVR improved 
significantly more in the memory scale than the TAVI participants (Alassar et al., 2015). 
Using DW-MRI, new cerebral lesions were found in 76% of TAVI and 72% of AVR 
patients at the 6-day follow-up (Alassar et al., 2015). Sixty-three percent (37 of 59) of the 
TAVI patients had lesions remain visible at 3 months (Alassar et al., 2015). The authors 
report that there was no association between cerebral lesions and cognitive performance.  
 The present study will include a more comprehensive neuropsychological 
evaluation than many previous TAVI studies. Included in the evaluation are cognitive 
measures that are more sensitive to cognitive changes in older adults (e.g., Repeatable 
Battery for the Assessment of Neuropsychological Status) and will contain additional 
measures of cognitive domains that are affected by cardiovascular disease (e.g., 
processing speed and mental control (Saxton et al., 2000)). The present study will also 
assess depressive symptoms, which previous cognitive TAVI studies have not addressed. 
Daily functioning measures (i.e., activities of daily living) were also included in the 
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present study to examine how cognitive changes, mood, and TAVI procedure relate to the 
patients' ability to function. 
TAVI and Quality of Life 
Activities of Daily Living 
 Functionality is divided into two areas: basic activities of daily living (BADL) 
and instrumental activities of daily living (IADL). BADLs include every day self-care 
activities such as eating, hygiene, dressing, and toileting. IADLs are tasks that allow 
more independent living, such as medication management, money management, 
housework, use of communication, and use of transportation. Cognitive deficit prior to 
cardiac surgery (valve replacement, CABG or combined) predicts changes in IADLs 
three months after the procedure (Messerotti Benvenuti, Patron, Zanatta, Polesel, 
Palomba, 2014). Preoperative cognitive status was also a stronger predictor of decline in 
IADLs at three months than postoperative cognitive decline (Messerotti Benvenuti et al., 
2014). Previous studies have indicated that BADL level, frailty, and physical mobility 
significantly predicted all-cause mortality and major adverse cardiovascular and cerebral 
events in patients following the TAVI procedure (Stortecky et al., 2012). Patients with 
reduced BADL may have reduced adaptive capacities and fewer physiological reserves to 
recover from the TAVI procedure. 
Quality of Life 
 Neurological injury following cardiac surgery potentially decreases quality of life 
(Newman, Grocott, Mathew et al., 2001). Quality of life (QOL) assessments often 
include multiple measures of activity level, mood, perceived social support, working 
status, social functioning, and health status. Level of activity measurements include 
	   	  
	  21 
assessment of ADLs (i.e., personal care, ambulation, and household tasks) as well as 
general activity level (Newman, Grocott, Mathew  et al., 2001). Although often only a 
component of the QOL assessment, significant changes in ADL can likely greatly 
influence a person's quality of life. 
 Fairbairn et al. (2012) examined health-related quality of life (HLQOL) of 102 
patients undergoing the TAVI procedure. The patients completed the Social Functioning 
12v2 health outcomes questionnaire and the Euro Quality of Life (EQ-5D) questionnaire 
at baseline, 30 days, 6 months, and 1 year. The EQ-5D measures five dimensions of 
quality of life: mobility, self-care, pain/discomfort, usual activities, and mood 
(anxiety/depression). The patients demonstrated an increase in quality of life from 
baseline to 30 days and to 6 months. A nonsignificant drop in HLQOL occurred from 6 
months to 1 year. Predictors of increases in QOL were male gender and the surgeon's 
experience with the TAVI procedure. The operator experience was an independent 
predictor of QOL over complications and procedural factors (e.g., transfusion or aortic 
regurgitation) (Fairburn et al., 2012).  
Mood 
 Depressive symptoms, a component often assessed in QOL, also have important 
cardiovascular and cognitive implications. Depression increases risk of cardiovascular 
disease and increases mortality of patients with cardiovascular disease (Lett et al., 2004). 
Depression also increases risk of stroke (Pan, Sun, Okereke, Rexrode, & Hu, 2011). 
Cardiovascular disease and cerebral injury can contribute to developing late-life onset 
depression (Taylor, Aizenstein, & Alexopoulos, 2013). 
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 Self-reported high levels of mood symptoms have also been shown to negatively 
affect neuropsychological testing following cardiac surgery (Andrew, Baker, Kneebone, 
& Knight, 2000). Patients undergoing cardiac surgery (n = 147) were given a 
neuropsychological evaluation preoperatively (the day before the procedure) and at 
discharge (mean = 6.5 days) (Andrew et al., 2000). The neuropsychological evaluation 
included the California Verbal Learning Test (CVLT), Purdue pegboard, Controlled Oral 
Word Association Test letter fluency, Trail Making Test (TMT) A and B, Wechsler Adult 
Intelligence Scale - Revised: Digit Symbol subtest, Boston Naming Test, National Adults 
Reading Test- Revised. Mood symptoms were measured using the Depression Anxiety 
Stress Scales (DASS). The DASS is a 14 item self-report measure that requires the 
participant to indicate both severity and frequency of anxious and depressive symptoms. 
Twenty percent of the patients indicated symptoms of depression following the surgery, 
of which the majority indicated depression prior to the surgery, as well. Reported anxiety 
and stress on the DASS was a significant predictor of postoperative mood. Pre and 
postoperative depression and anxiety significantly predicted deficits on TMT A, CVLT 
total recall, and CVLT recognition discrimination (cognitive areas of attention and verbal 
memory). Preoperative mood failed to predict preoperative neuropsychological tests. 
Although postoperative mood symptoms were significant predictors of 
neuropsychological deficit on several tests, these relationships were diminished to 
nonsignificant when preoperative mood symptoms were used as a covariate (Andrew et 
al, 2000). The above study demonstrates a complex relationship between mood 
symptoms and neuropsychological measures in cardiac surgery patients. The addition of 
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mood measures in the present study may help identify factors influencing cognition in 
TAVI patients.  
Frailty 
 Frailty will also be addressed in the present study. Frailty exhibited in the geriatric 
population is defined as being "characterized by an increased vulnerability to stressors, 
leading to increased risk of negative health-related events (including falls, disability, 
hospitalizations, and mortality)" (Houles et al., 2012). Frailty does not have a 
standardized measure, and studies often use differing criteria to establish frailty (Houles 
et al, 2012). Physical frailty and cognitive impairment often co-occur (Yassuda et al., 
2012), and physical frailty with cognitive impairment is predictive of future disability 
(Ávila-Funes et al., 2011). Frailty, when assessed combining independence in ADLs, gait 
speed, grip strength, and serum albumin, is a significant predictor of mortality rates at 
one year in TAVI patients (Green et al., 2012). Frailty status was not related to TAVI 
procedural complications immediately following the procedure (Green et al., 2012). Gait 
speed alone also indicates frailty. Slowed gait speed, defined as walking 5 meters in ≥6 
seconds, is an independent predictor of mortality and major morbidity (e.g. stroke, renal 
failure, etc) in older adults following cardiac surgery (Alfiano et al., 2010). 
 The Kansas City Cardiomyopathy Questionnaire (KCCQ) (Green, Porter, 
Bresnahan, & Spertus, 2000) is a 23-item, self-report assessment that measures symptoms 
(frequency and severity), physical function, self-efficacy and knowledge, social function, 
and quality of life in patients with heart failure (Green et al., 2000). The KCCQ is valid 
measure of symptoms and quality of life in patients with aortic stenosis (Arnold et al., 
2013). The KCCQ demonstrated adequate reliability and the domains of the KCCQ 
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showed positive correlations with relevant reference measures (Arnold et al., 2013). 
TAVI patients score significantly higher on the KCCQ overall summary score at one 
month compared to baseline (p<.001, d = 0.94; Arnold et al., 2013).  
Present Study 
 The present study will further our understanding of cognitive changes following 
the TAVI procedure. TAVI is associated with an increased risk of silent ischemic injury 
(Arnold et al., 2010; Ghanem et al., 2010; Kahlert et al, 2010; Rodes-Cabau et al., 2011). 
Despite the risk of cerebral injury, many studies have failed to assess cognition or only 
examined cognitive function through a global cognitive measure (i.e., Mini-Mental State 
Examination) (Rodes-Cabau et al., 2011; Kahlert et al., 2010). Most studies using the 
MMSE have failed to find cognitive changes following TAVI. In the studies using more 
comprehensive cognitive assessment, cognitive abilities appear stable with some 
improvements (Ghanem et al, 2013; Alassar et al., 2015). Ghanem and colleagues (2013) 
found improvement on RBANS total score three days and two years after the TAVI. 
Similarly, Alasssar and colleagues (2015) observed significant improvement at three 
months post-TAVI in overall cognitive measures and on the memory sub-scale. The 
present study will also use the RBANS, which has demonstrated sensitivity to cognitive 
changes in the TAVI population (see Ghanem et al, 2013), and it will include additional 
measures of processing speed, mental control, and executive function. Processing speed 
and mental control are cognitive domains negatively affected by cardiovascular disease 
(Saxton et al., 2000). In the present study, we predict that the participants will show a 
significant improvement in processing speed, attention, executive function, and mental 
control. More specifically, we anticipate results similar to Ghanem et al. (2013) with 
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significant improvement on the RBANS Immediate Memory Index and the RBANS 
Language Index scores.  
  The present study will also include non-cognitive measures (mood, functional 
ability, and frailty) that have been associated with cognition and overall quality of life. 
Research supports improved quality of life following the TAVI (Fairburn et al., 2012). 
We predict that in addition to improvements in self-reported quality of life, we will also 
find improvements in functional ability and frailty status. 
 Previous studies indicate that a subset of new ischemia observed on neuroimaging 
within days following the TAVI procedure will resolve (Alassar et al., 2015; Knipp et al., 
2013). Therefore, the present study will examine neuroimaging at one month to more 
accurately detect permanent neuronal damage.  We predict that the rate of ischemic injury 
will be lower than previous estimations (e.g., 84% in Kahlert et al., 2010) due to the one-
month delay. The cognitive sequelae of ischemia following cardiac procedures are 
debated (see above). Recent studies using MRI in TAVI patients fail to support that 
ischemic changes have a significant effect on cognition (Ghanem et al, 2013; Alassar et 
al., 2015). Therefore, new lesions are predicted to have no relationship with postoperative 
cognitive functioning.  Instead, medical variables, such as procedure length and chronic 
kidney disease have been associated with post-operative cognitive decline (Ghanem et 
al., 2013). We predict that the measures of overall medical health (i.e., the Society for 
Thoracic Surgeons score) and procedural variables (i.e., procedure length) will predict 
post-operative cognitive performance. 
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CHAPTER II 
METHOD 
Participants 
 The interventional cardiologist at The Sanford Medical Center in Fargo, North 
Dakota identified patients eligible for the TAVI procedure, and a clinical research 
coordinator obtained informed consent. Participants completed a baseline cognitive 
assessment and DW-MRI one day prior to the TAVI procedure and at a one-month 
follow-up (30.67 day ± 5.46). Participants with diminished capacity to consent were 
excluded from the study. Patients non-fluent in English were excluded. As the TAVI 
procedure is an alternative procedure for high mortality risk patients, patients with health-
related issues that may affect cognition were not excluded. Specifically, uncontrolled 
hypertension, coronary artery disease, carotid disease, chronic obstructive pulmonary 
disease, parkinsonism, history of stroke, history of cancer, history of prior CABG are 
common in the TAVI population and may affect cognition. However, patients with the 
above conditions were not excluded, as they are believed to be representative of the 
population. Patients needing combined heart surgery (i.e., multiple valve disease, patent 
foramen ovale, etc.) or multiple vascular surgeries (i.e., ascending aortic aneurysm and 
carotid revascularization) were excluded. To reduce attrition, noncompliant patients, as 
defined as an inability to complete the Mini-Mental State examination and the RBANS 
were excluded. Patients were excluded from the neuroimaging portion of the study when 
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an MRI was contraindicated (e.g., claustrophobia, internal ferromagnetic material as a 
result of trauma, surgery, or implant), but the cognitive evaluation was still completed. 
 Fifty participants were recruited from Sanford Medical Center in Fargo, North 
Dakota. Forty participants were seen at one month. Three participants died before the 
follow-up. Deaths resulted from TAVI complications including embolic event to the 
bowels (death 2 days post-TAVI), aortic dissection (death 5 days post-TAVI), and during 
the TAVI procedure (surgical complications). Three participants chose to withdraw at the 
follow-up: one participant was hospitalized during the follow-up and cited poor health as 
the reason for withdrawal; one participant failed to attend the follow-up appointment and 
withdrew when contacted to reschedule. One participant did not tolerate cognitive testing 
at the follow-up and failed to complete the MMSE and RBANS. Two participants 
completed the baseline evaluation, but the TAVI procedure was canceled or delayed due 
to medical conditions or patient decision (i.e., urinary tract infection, decided to forgo the 
intervention). A scheduling error resulted in one participant failing to complete the 
follow-up. 
Cognitive Evaluation 
 Participants completed cognitive testing within 24 hours prior to the procedure 
and 30.67 ± 5.46 days later. The follow-up cognitive assessment was scheduled to 
coordinate with the TAVI postoperative medical follow-up. The following tests were 
administered during the first testing session: Mini-Mental State Exam (Folstein, Folstein, 
& McHugh, 1975), Wechsler Test of Adult Reading (Holdnack, 2001), Repeatable 
Battery for the Assessment of Neuropsychological Status (RBANS; Randolph, 1998), 
Stroop Color-Word Interference Test (Golden, 1978), Trail Making Test A and B (Reitan 
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& Wolfson, 1993), Letter Fluency (Benton & Hashmer, 1983), Verbal Series Attention 
Test (Mahurin & Cooke, 1996), Wechsler Adult Intelligence Scale–Fourth Edition 
(WAIS-IV) Digit Span subtest (Wechsler, 2008), and the Geriatric Depression Scale 
(Yesavage, Brink, Rose, Lum, & Huang, 1983). The follow-up examination was identical 
except the Wechsler Test of Adult Reading was not administered. The RBANS has two 
alternate forms: RBANS-A and RBANS-B. Administration was counterbalanced such 
that half of the participants completed RBANS-A initially and RBANS-B at the follow-
up, and the other half completed RBANS-B during the pre-procedure assessment and 
RBANS-A during the follow-up. A family member or caregiver completed the informant 
questionnaires (Functional Activities Questionnaire (Pfeffer, Kurosaki, Harrah, Chance, 
& Filos, 1982), Physical Self Maintenance Scale (Lawton & Brody, 1969), and the 
Dementia Severity Rating Scale (Clark & Ewbank, 1996)) during the pre- and post-TAVI 
evaluations. 
Cognitive Assessment Materials  
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) 
 The RBANS is a brief cognitive battery developed to screen for cognitive decline 
in older adults.  The RBANS contains 12 subtests and takes approximately 25 minutes to 
administer. Subtests are combined to yield 5 indices: Immediate Memory, 
Visuospatial/Constructional, Language, Attention, and Delayed Memory. Indices can be 
combined to calculate a Total Scale Score. the RBANS test-retest reliability was 
calculated for retest intervals between 1 and 134 days, and the length of the interval did 
not significantly affect the test-retest reliability. The RBANS subtest test-retest reliability 
coefficients range from 0.52 (List Learning) to 0.83 (Coding), and the indices test-retest 
	   	  
	  29 
reliability coefficients range from 0.68 (Visuospatial/Constructional) to 0.80 (Delayed 
Memory; Randolf, 2012). In construct validity studies, the RBANS subtests correlated 
with measures of similar cognitive abilities; for example RBANS 
Visuospatial/Constructional Index correlated highly with the Rey-Osterrieth Complex 
Figure Copy, and the RBANS Attention Index correlated highly with the Wechsler 
Memory Scales - Revised Attention/Concentration Index (Randolf, 2012). The RBANS 
subtests are described below. 
 1) List Learning and Story Memory subtests comprise the Immediate Memory 
Index. During List Learning, individuals learn a verbally presented 10-word list over four 
trials. Scores are recorded for recall after each trial and for total recall over all four trials. 
In Story Memory, individuals learn a story containing 12 parts or ideas over two verbally 
presented trials. Scores are calculated by combining story part recall for each trial. 
 2) Visuospatial/Constructional index contains the subtests Figure Copy and Line 
Orientation. The Figure Copy requires the participants to copy a 10-part geometrically 
complex figure. A four-minute time limit is given for Figure Copy, which far exceeds the 
time necessary for most people to complete the task. Time required to complete the 
drawing is recorded, but does not influence the Figure Copy score. The participants are 
instructed that they are timed during the Figure Copy, but that their score is based on the 
accuracy of the drawing. The Line Orientation subtest requires individuals to correctly 
identify the matching orientation of two target lines to a 13-line array spanning 180 
degrees. 
 3) The Language index consists of Picture Name and Semantic Fluency subtests. 
Picture Naming requires the individual to name line drawings of objects. If the individual 
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misperceives the picture, a semantic cue is given. In Semantic Fluency, participants are 
presented with a category (e.g., Fruits and Vegetable) and have 60 seconds to generate 
words within the category. 
 4) Digit Span and Coding comprise the Attention Index. The Digit Span subtest 
requires the participant to repeat verbatim strings of digits verbally presented by the 
examiner. During the Coding subtest, participants quickly match numbers to a series of 
symbols using a key. Coding is a timed test. 
 5) List Recall, List Recognition, Story, Recall, and Figure Recall comprise the 
Delayed Memory Index. List Recall is a free recall measure from the word list presented 
in List Learning. The List Recognition subtest requires the participant to identify the 
word list words amongst distracters by providing "yes" or "no" responses. The Story 
Recall subtest is a free recall task for the story presented in Story Memory. The Figure 
Recall subtest requires the participant to draw the geometric figure from Figure Copy 
from memory with no time limit. All delayed recall subtests occur approximately 10-15 
minutes after the original stimulus presentation.  
 The figure copy and recall were scored with awareness to pre and post-TAVI 
status. Ten percent of the figures were re-scored by a research assistant blinded to the 
pre- and post-TAVI status. The calculated inter-rater reliability percent agreement was 
0.93, indicating adequate scoring agreement. 
Mini-Mental State Examination 
 The Mini-Mental State Examination (MMSE) is a global cognitive screening 
measure (Folstein, Folstein, & McHugh, 1975). The MMSE consists of brief 
measurements of multiple cognitive domains, including orientation to time and place, 
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memory encoding and recall, complex attention, language production and reception, and 
visuospatial/constructional abilities. The MMSE has adequate reliability and 
demonstrates good validity, as evidenced by high correlations with criteria measures of 
cognitive impairment (i.e., the Diagnostic and Statistical Manual for Mental Disorders 
and the National Institute of Neurological and Communicative Disorders and Stroke- 
Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) Alzheimer's 
criteria; Tombaugh & McIntyre, 1992). The MMSE is often used as a dementia screening 
in older adults with scores < 24 representing probable cognitive impairment (Folstein, 
Folstein, & McHugh, 1975). 
Stroop Color-Word Interference Test 
 The Stroop Color-Word Interference Test (Golden, 1978) consists of three 
sections, each with a 45 second time limit. In the first section, the participant is required 
to read a list of color words (e.g., red, blue, etc.) at a rapid rate. In the second section, the 
participant is presented a list of X's printed in different colors. The second section 
requires the participant to provide the color of ink the series of X's is printed in (e.g., 
"XXXXX" printed in red ink and the participant would respond "red") at a rapid rate. For 
the third section, the participant is presented with color words printed in incongruent ink 
colors (e.g., the word "red" written in blue ink). The participant is required to rapidly 
provide the ink color while ignoring the word. The first two sections of the Stroop 
provide processing speed measures. The third section measures inhibition, an executive 
function requiring attention and inhibition of prepotent responses (i.e., reading the written 
word). The test-retest reliability for the three trials are 0.89, 0.84, and 0.73, respectively 
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(Golden, 1975). The third trial (Word-Color interference) correlates with established 
measures of prepotent response inhibition and attention (May and Hasher, 1998). 
Test of Premorbid Functioning 
 The Test of Premorbid Functioning (Wechsler Test of Adult Reading: WTAR) 
requires the participant to read aloud a list of words (Holdnack, 2001). The WTAR words 
have atypical pronunciations based on common English rules (e.g., ogre). The WTAR is 
used to estimate overall cognitive ability prior to a cerebral injury, such as traumatic 
brain injury or degenerative disease. The WTAR demonstrates adequate reliability and 
correlates well with verbal intelligence quotients (Whitney, Shepard, Mariner, 
Mossbarger, Herman, 2010). 
Trail Making Test A and B 
 The Trail Making Test (TMT) consists of two subtests (Reitan & Wolfson, 1993). 
In the first subtest (Trail A), participants are presented a page with circles each 
containing a number (unordered). The participant is required to connect the numbers in 
ascending numerical order at a fast rate without error. In the second subtest (Trail B), 
participants are presented a page with circles each containing a number or a letter. The 
participant is required to connect the circles in alternating order (1 to A, A to 2, 2 to B, B 
to 3, etc.) at a rapid rate without error (Reitan & Wolfson, 1993). The test-retest 
reliability for TMT Part A is 0.79 and 0.89 for Part B (Dikmen, Heaton, Grant, & 
Temkin, 1999). TMT Part A measures primarily visual search and processing speed; 
TMT Part B measures both working memory and task-switching performance (Sanchez-
Cubillo et al., 2009)  
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Letter Fluency 
 In letter fluency, participants are given a letter and asked to generate words that 
begin with that letter (Benton & Hashmer, 1983). Letter fluency consists of three 60-
second trials with a different letter in each trial. Letter fluency is a well-established 
neuropsychological assessment measure of executive function, verbal ability, and 
processing speed (Strauss, Sherman & Spreen, 2006, pp. 499- 526).  
Verbal Series Attention Test 
 The Verbal Series Attention Test (VSAT; Mahurin & Cooke, 1996) requires the 
participant to say series of letters, words, or numbers. Participants are informed that 
speed and accuracy are important. The VSAT requires verbal recall and/or mental 
manipulation of overlearned material (e.g., "say the alphabet"; "say the days of the week 
backward", etc.). The VSAT generates scores for overall time to complete the items and 
number of errors. The VSAT is a measure of mental control and attention. The VSAT 
Time score has good test-retest reliability (r = 0.86), and adequate construct validity as a 
measure of attention (i.e., highly correlates with the WAIS-R Freedom From 
Distractibility factor; Mahurin & Cooke, 1996). 
WAIS-IV Digit Span Subtest 
 For the present study, only the backward subsection of the Digit Span subtest was 
completed. During Digit Span Backward, the examiner reads a series of numbers and the 
participant is required to repeat the series in reverse order. The number strings increase in 
length until the participant can no longer complete the task correctly. Digit Span 
Backward measures complex attention. The Digit Span backward test is a measure of 
working memory (Wechsler, 2008). 
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Geriatric Depression Scale 
 The Geriatric Depression Scale (GDS) is a 30-item yes/no response, self-report 
questionnaire developed to measure depressive symptoms in older adults (Yesavage et 
al., 1983). The test items focus on the psychological symptoms associated with 
depression and excludes physiological symptoms that are more likely confounded by age 
and disease. The GDS demonstrates adequate internal consistency and correlates highly 
with other measures of depression in an elderly sample (Yesavage et al., 1983). 
Informant Questionnaires 
 The informant questionnaires assess the participant's level of functioning through 
a caretaker's report. The Physical Self-Maintenance Questionnaire (PSMS; Lawton & 
Brody, 1969) is a multiple-choice questionnaire that assesses level of independence in the 
following basic activities of daily living (BADLs): toilet use, feeding, dressing, 
grooming, physical ambulation, and bathing. The PSMS has test-retest reliability of 0.94 
and has high correlations with physicians' ratings and other measures of activities of daily 
living (Lawton & Brody, 1969). The Functional Activities Questionnaire (FAQ; Pfeffer, 
Kurosaki, Harrah, Chance, & Filos, 1982) measures instrumental activities of daily living 
(IADLs) such as managing personal finances and meal preparation. The FAQ has high 
inter-rater reliability and adequately discriminates normal controls from patients with 
dementia (Pfeffer et al., 1982). Typically, IADLs represent activities that require higher 
cognitive function than BADLs. The Dementia Severity Rating Scale (DSRS; Clark & 
Ewbank, 1996) is a multiple-choice questionnaire measuring major cognitive and 
functional typically impaired in individuals with dementia. The DSRS has good test-
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retest reliability and correlates highly with cognitive measures and with other validated 
measures of dementia severity (Clark & Ewbank, 1996). 
Frailty Measures  
 The frailty assessment included the gait speed, the KCCQ, and fatigue/exhaustion. 
The Kansas City Cardiomyopathy Questionnaire (KCCQ; Green, Porter, Bresnahan, & 
Spertus, 2000) was used to measure activity level and quality of life. The KCCQ is 
included in the standard pre and post TAVI evaluations by the heart team. The KCCQ is 
a 23-item, self-report assessment that measures symptoms (frequency and severity), 
physical function, self-efficacy and knowledge, social function, and quality of life in 
patients with heart failure (Green et al., 2000). Two questions from the Center for 
Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) ("I felt that everything I 
did was an effort" and "I could not get going") were included at the end of the GDS as a 
measure of frailty. The two CES-D questions as exhaustion measures have been used in 
previous research of frailty and surgical outcomes (Makary et al., 2010). Patients rating 
either question with a 2 (occurred 3-4 days in the past week) or 3 (occurred 5-7 days in 
the past week) on either question meet criteria for exhaustion. As a measure of gait speed, 
patients were asked walk 5 meters at walking speed. Participants with ≥6 seconds on the 
5 meter walking test met criteria for frailty (Alfiano, Eisenberg, Morin, et al., 2010). 
Participants responding with a "2" or "3" on either CES-D question and with a gait speed 
greater than 6 seconds qualified as frail in the present study.   
Magnetic Resonance Imaging 
 MRI data was acquired within 24 hours pre-TAVI and at the 1-month follow-up. 
A 1.5T magnet utilizing a standard head was used for imaging. Images were assessed for 
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small vessel ischemic change, old infarcts, microhemorrhages, and acute ischemia by a 
neuroradiologist at Sanford Health. Medically relevant findings from the MRIs, as 
determined by the radiologist and interventional cardiologist, were shared with the patient 
as necessary. Data collected from the MRI images will include number new ischemic 
lesions.  
Medical Variables 
 Variables with prior research to support their use in the present study were 
extracted from the participants' medical records. Medical variables of interest are listed in 
completion in Table 1. For purposes of the present study, presence of coronary artery 
disease, uncontrolled hypertension, history of neurological disease, history of prior 
coronary artery bypass grafting, chronic kidney disease and chronic obstructive 
pulmonary disease were extracted from electronic medical records for general 
demographics of the TAVI patient population health status. As TAVI procedure length 
potentially influences post-TAVI cognitive outcomes (Ghanem et al., 2013), it was also 
included in further analyses. 
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CHAPTER III 
RESULTS 
Data Screening 
 All variables were examined for outliers and normality. Using an a priori 
criterion of beyond two standard deviations, no outliers were eliminated from any 
variables. Normality was assessed using the Shapiro-Wilk test of normality and Fisher's 
coefficient for skewness and kurtosis measures. Shapiro-Wilk values with p < 0.05 
indicate the variable is not normally distributed. Fisher's coefficient is calculated using 
skewness divided by the standard error of skewness, and calculated values outside of 
±1.96 indicate the distribution is significantly skewed (Howell, 2010, Chapter 2). The 
following variables were not normally distributed: RBANS (Line Orientation, Picture 
Naming, List Recall, List Recognition, Figure Recall), Digit Span Backward, Verbal 
Series Attention Test, Trail Making A Time, Trail Making B Time, and all informant 
rating scales.  
 Variables that failed normal distribution measures were transformed to improve 
their normality. The type of data transformation was determined by the skewness 
direction (i.e., positive or negative) and the severity of the skewness (i.e., moderate, 
substantial, or severe). For positively skewed distributions, data were transformed using 
formulas in Mertler and Vannatta (2010, p. 32) by attempting transformations for 
moderate skewness (square root) then substantial skewness (logarithm) then severe 
skewness (inverse) until normality was achieved. For distributions negatively skewed, 
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data were reflected (i.e., (K - X), in which the constant (K) creates the smallest value of 
one) before their subsequent transformation (Mertler & Vanatta, 2010, p. 31). Reflection 
causes the distribution to become positively skewed, and the subsequent transformation 
(i.e., square root, logarithmic, or inverse) to correct the positive skewness to a more 
normal distribution (Mertler & Vanatta, 2010, p. 31) The RBANS List Recall Raw 
distribution was positively skewed (post-TAVI Fisher coefficient = 2.70), and data were 
transformed using the inverse to achieve normality. The RBANS Figure Recall pre-TAVI 
had a significant Shapiro-Wilk value (p = 0.014). Pre and Post RBANS Figure Recall 
data were transformed using reflection and square root transformation. The pre and post-
TAVI Digit Span Backwards distributions were positively skewed, and the post-TAVI 
Digit Span Backward Shapiro-Wilk was significant (p = 0.009). A logarithmic 
transformation on Digit Span Backward raw score improved normality (Shapiro-Wilk 
value = 0.95, p = 0.11). The pre and post-TAVI Verbal Series Attention Test (VSAT) 
time also positively skewed. A logarithmic transformation on the VSAT Time improved 
normality (Shapiro-Wilk p > 0.05). The Trailmaking Test (TMT) A and B time for both 
pre- and post-TAVI were positively skewed. An inverse transformation for the TMT A 
Time was performed to improve normality (pre-TAVI TMT A Shapiro-Wilk p = 0.067, 
post-TAVI TMT A Shapiro-Wilk p = 0.58). A logarithmic transformation on TMT B 
time raw score improved normality (pre-TAVI Shapiro-Wilk value p = 0.49, post-TAVI 
Shapiro-Wilk value p = 0.79). The following variables did not achieve normality after 
transformations: RBANS Figure Copy, RBANS Line Orientation, RBANS Picture 
Naming, RBANS List Recognition, TMT A errors, TMT B errors, FAQ, DSRS, PSMS. 
 
	   	  
	  39 
Patient Characteristics 
 Patient characteristics are summarized in Table 2.  
Table 2 
 
Sample Baseline Characteristics 
Variable n Mean±SD Range 
Age 46 79.04±7.79 59-90 
Education Level 43 12.51±3.75 6-20 
WTAR Standard Score 
 
40 97.23±12.59 81-123 
Gender    
Male 29 -- -- 
Female 17 -- -- 
BMI 46 31.15±6.54 21-47 
STS Score 45 6.65±3.09 1.47-15.50 
EuroScore 19 9.07±5.54 1.06-20.36 
Diabetes 18 (39%) -- -- 
     Type I 2 -- -- 
     Type II 16 -- -- 
NYHA Class 32 -- -- 
     I 4 -- -- 
     II 8 -- -- 
     III 19 -- -- 
     IV 1 -- -- 
CKD 16 (35%) -- -- 
Hyperlipidemia 33 (72%) -- -- 
Hypertension 34 (74%) -- -- 
COPD 7 (15%) -- -- 
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Table 2. cont.    
Variable n Mean±SD Range 
Mood Disorder 11 (24%) -- -- 
     Depression 6 (13%) -- -- 
     Anxiety 2 (4%) -- -- 
    Mixed Anxiety/    
Depression or 
unspecified 
3 (7%) -- -- 
Carotid Disease 9 (20%) -- -- 
CAD  33 (72%) -- -- 
     Prior CABG 14 (31%) -- -- 
BMI = body mass index; STS = The Society for Thoracic Surgeon's risk score; NYHA 
= New York Heart Association Functional Classification; CKD = chronic kidney 
disease; COPD = chronic obstructive pulmonary disease; CAD =  coronary artery 
disease 
 
Procedural Characteristics 
 TAVI procedural characteristic data were collected for 46 participants. Table 3 
summarizes these data. 
Table 3 
 
TAVI Procedural Data 
Variable n Mean±SD 
Valve Type 46 -- 
     Edward SAPIEN 34 -- 
     CoreValve 
 
12 -- 
Valve Size -- -- 
     23 mm 14 -- 
     26 mm 17 -- 
     29 mm 8 -- 
     31 mm 7 -- 
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Table 3. cont.   
Variable n Mean±SD 
Procedure Route   
     Transfemoral 36  
     Transapical 9  
Valve in Valve 2 -- 
Pre- Mean Gradient 44 46.84±8.28 
Post- Mean Gradient 39 11.31±5.10 
Procedure Length 
(minutes) 
149.9 98±212 
Length of Stay 43 4.05±4.91 
Edward SAPIEN = transcatheter heart valve, Edwards Lifesciences 
device; CoreValve = Medtronic transcatheter aortic valve replacement 
system  
 
 
Cognitive Assessment 
 Dependent t-tests were used to compare pre and post-TAVI cognitive measures. 
Variables not normally distributed were excluded from the analyses. 
 The results for the RBANS t-tests are presented in Table 4. Results of the 
dependent t-test using the RBANS show that the Language Index significantly differs 
from baseline (M = 91.42, SD = 9.04) to one month post-TAVI (M = 95.50, SD = 10.86, t 
= -2.59, df = 37, p = 0.014, d = 0.42). The participants scored, on average, 4.08 points 
higher at one month than prior to the TAVI procedure.  
 At the RBANS subtest level, results of the dependent t-test show that the Fluency 
subtest improved significantly from baseline to one month post-TAVI (p = 0.023, d = 
0.38).  Results also show significant decline on the List Recall subtest from baseline (M = 
3.21, SD = 2.22) to one-month post-TAVI (p = 0.001, d = 0.56). On average, participants 
recalled about one less word (mean difference = 0.90) at one month than baseline. Results  
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Table 4. 
RBANS Dependent t-tests comparing baseline and one month post-TAVI 
 Pretest   Posttest    
Variable 
 
M SD  M SD t df 
RBANS Total 
Index 
 
85.26d 14.69  85.74d 13.41 -0.33 34 
Immediate 
Memory Index 
 
84.33d 15.76  84.46d 15.85 -0.055 38 
List Learning 
 
19.80 5.49  19.43 5.32 0.43 39 
Story Learning 
 
12.97 4.39  13.33 4.80 -0.56 38 
Visuospatial/ 
Constructional 
Index 
 
92.11d 18.90  89.66d 17.77 0.96 37 
Figure Copyc 
 
16.36 2.67  16.41 3.13 -- -- 
Line Orientationc 
 
14.76 4.58  14.03 4.89 -- -- 
Language Index 
 
91.42d 9.04  95.50d 10.86 -2.59* 37 
 Picture Namingc 
 
9.36 0.84  9.46 0.72 -- -- 
Fluency 
 
14.59 3.57  16.10 4.35 -2.36* 38 
Attention Index 
 
87.25d 15.74  86.89d 14.50 0.18 35 
Digit Span 
 
8.92 2.07  8.67 2.11 0.79 38 
Coding 
 
29.58 9.42  29.89 9.53 -0.37 35 
Delayed Index 
 
85.63d 16.42  87.55d 15.81 -0.87 37 
List Recalla 
 
3.21 2.22  2.31 2.23 -3.44* 37 
List Recognitionc 
 
17.55 1.95  17.45 2.18 -- -- 
Story Recall 
 
6.44 2.81  6.64 2.93 -0.48 38 
Figure Recallb 9.51 5.62  10.85 5.31 2.31* 37 
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Table 4. cont. 
M = mean, SD = standard deviation, df = degrees of freedom,  
a t-test completed with inverse transformation data to achieve normality 
b t-test completed with reflected a square root transformation to achieve normality 
c t-test not completed due to failure to meet assumptions 
d standard scores derived from raw score transformations using RBANS Manual 
* p < 0.05 
 
show significant improvement on the Figure Recall subtest from baseline to one month 
post-TAVI (p = 0.027, d = 0.37). No other significant differences were observed between 
baseline and at one month on RBANS measures.  
 Dependent t-tests comparing baseline to one month post-TAVI were completed 
for the following cognitive measures: Trailmaking Test A and B, Verbal Series Attention 
Test, WAIS-IV Digit Span Backward, Letter Fluency, Stroop Color-Word Interference 
Test, Mini-Mental State Examination. Results are presented in Table 5. No significant 
differences were observed. 
Table 5. 
 
Dependent t-tests comparing baseline and one month post-TAVI on cognitive measures 
 Pretest   Posttest    
Variable 
 
M SD  M SD t df 
MMSE 
 
25.88 2.81  25.75 3.17 0.321 39 
VSAT Timea 
 
130.50 41.22  130.20 46.33 0.23 34 
Trail Making Test 
 
-- --  -- -- -- -- 
A: Time (sec)a 
 
51.44 25.45  56.38 32.88 -1.62 33 
A: Errorb 
 
0.05 0.22  0.18 0.46 -- -- 
B: Time (sec)a 
 
139.28 61.48  151.96 80.86 -1.31 24 
B: Errorb 
 
0.53 0.80  0.93 1.04 -- -- 
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Table 5. cont.        
 Pretest   Posttest    
Variable 
 
M SD  M SD t df 
Digit Span 
Backwarda 
 
7.26 1.83  8.67 2.11 0.27 34 
Stroop 
 
-- --  -- -- -- -- 
Word 
 
72.72 15.27  73.52 15.41 -0.41 32 
Color 
 
49.31 10.54  49.28 12.57 0.02 31 
Word-Color 
 
22.25 7.06  24.53 8.53 -1.94 31 
Letter Fluency 
 
25.51 11.83  27.43 11.01 -0.73 34 
a t-test completed with logarithmic transformation data to achieve normality 
b t-test not completed due to failure to meet assumptions 
 
 A standard multiple regression was conducted to determine if the independent 
variables procedure length, difference in mean gradient, and STS score predict the change 
in RBANS Total Index Score. Procedure length is an indirect measure of the operation 
complexity. The mean gradient is a measure of valve efficiency, and is routinely used to 
measure the severity of aortic stenosis. The STS score represents an estimated mortality 
percentage that is obtained using an algorithm that combines multiple chronic medical 
conditions and previous cardiovascular risk factors. Regression results indicate that the 
overall model does not significantly predict the change in RBANS Total Index scores 
(R2adj = 0.008, F(3,27) = 0.946, p = 0.375). The model accounts for 10.6% of the variance 
in the change in RBANS Total Index score in the sample. The regression coefficients are 
presented in Table 6. 
 The regression was repeated with the same independent variables to predict 
change in scores that showed significant change on previous t-tests: RBANS Language  
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Table 6. 
 
Regression coefficients for model predicting change in RBANS Total Index score 
 ß t p Partial r 
Procedure Length 
(minutes) 
 
-0.167 1.754 0.091 -0.160 
STS score 
 
0.523 -0.316 0.754 -0.61 
Change in mean 
gradient 
 
0.211 -0.842 0.407 0.320 
STS = The Society for Thoracic Surgeon's risk score 
 
Index, RBANS Fluency, List Recall, and Figure Recall. In predicting RBANS Language 
Index change, regression results indicate that the overall model does not significantly 
predict the change in RBANS Language Index scores (R2adj = -0.050, F(3,28) = 0.504, p 
= 0.682). The model accounts for 5.1% of the variance in the change in RBANS 
Langauge Index score in the sample. In predicting RBANS Fluency change, regression 
results indicate that the overall model does not significantly predict the change in 
RBANS Fluency scores (R2adj = -0.076, F(3,29) = 0.244, p = 0.865). The model accounts 
for 2.46% of the variance in the change in RBANS Fluency subtest score in the sample. 
In predicting RBANS List Recall subtest raw score change, regression results indicate 
that the overall model does not significantly predict the difference (R2adj = 0.126, F(3,28) 
= 2.468, p = 0.081). The model accounts for 2.1% of the variance in the change in 
RBANS List Recall subtest score in the sample. In predicting RBANS Figure Recall 
subtest raw score change, regression results indicate that the overall model does not 
significantly predict change (R2adj = -0.016, F(3,28) = 0.836, p = 0.485). The model 
accounts for 8.2% of the variance in the change in RBANS Figure recall subtest score in 
the sample.  
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Mood, Quality of Life, and Frailty Assessment 
 Dependent t-tests were used to compare pre and post-TAVI quality of life 
measures. Variables not normally distributed were excluded from the t-test analyses. 
Results are summarized in Table 7. 
 Results of the GDS dependent t-test revealed a significant decrease from baseline 
to one month post-TAVI (p = 0.018, d = 0.41). The participants endorsed on average 1.50 
less depressive symptoms at one month than prior to the TAVI procedure. Results also 
show significant increase on the KCCQ from baseline to one-month post-TAVI (p < 
0.001, d = 1.08).  
Table 7. 
 
Dependent t-tests comparing baseline and one month post-TAVI on quality of life 
measures 
 Pretest   Posttest    
Variable 
 
M SD  M SD t df 
KCCQ 
 
38.93 9.81  51.55 9.99 -6.80** 39 
GDS 
 
7.33 4.78  5.83 4.09 2.47* 35 
Gait Speed 
 
5.77 1.59  5.32 1.56 1.56 34 
FAQ 
 
7.00 10.27  6.69 10.10 -- -- 
DSRS 
 
3.81 4.67  3.48 5.75 -- -- 
PSMS 
 
7.26 1.90  7.42 2.06 -- -- 
KCCQ = Kansas City Cardiomyopathy Questionnaire; GDS = Geriatric Depression Scale; FAQ = 
Functional Activities Questionnaire; DSRS = Dementia Severity Rating Scale; PSMS = Physical Self 
Maintenance Scale 
* p < 0.05 
** p < 0.001 
 
Participants were defined as "frail" when gait speed for 5 meter walk exceeded 6 seconds 
and at least one CES-D question was endorsed (see "Frailty" in literature review for 
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detailed description). Seven participants (7 of 37, 19%) met frailty criteria at baseline. 
Two participants (2 of 34, 6%) met frailty criteria at one month. Five participants that 
were frail at baseline were no longer frail at one month, and two participants maintained 
frailty status at one month. A summary of the frailty characteristics is presented in Table 
8. No statistical analyses were conducted on the frailty data. 
Table 8 
 
Summary of group data for participants meeting frailty criteria 
 n MMSE RBANS GDS 
Frail at baseline 7 27.4 73.9 10.7 
Frail at one month 2 24.5 78 9 
RBANS = Repeatable Battery for the Assessment of Neuropsychological Status 
Total Index Score mean; Frail = gait speed >6 seconds/5meters and 
endorsement on at least one CES-D question for frailty; MMSE = Mini-Mental 
State Examination mean; GDS = Geriatric Depression Scale 
 
Neuroimaging and Cognitive Performance 
 Thirty-five baseline and 22 one-month follow-up MRI protocols were completed. 
Six participants (27.2%) evidenced new ischemic lesions at one month. Characteristics 
and cognitive performances for participants with evidence of new ischemia are presented 
in Table 9. 
 A series of Mann-Whitney U tests were computed to compare cognitive 
performance in participants with new lesions (n = 6) to those without (n = 16). 
Participants with new ischemia were not significantly different than those without 
ischemia on post-TAVI RBANS Total Index (U = 37, z = -0.81, p = 0.45). Participants 
with new ischemia did not significantly differ from participants without new ischemia on 
RBANS Index scores (Immediate Memory Index, U = 40, z = -0.59, p = 0.59;  
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Table 9 
 
Characteristics of participants with new ischemia evidenced on MRI at one month 
 Baseline Follow-up  
Participant RBANS MMSE RBANS MMSE Change 
1 110 27 103 29 -7 
2 82 23 82 23 0 
3 91 28 68 28 -23* 
4 70 26 76 22 +6 
5 70 23 73 26 +3 
6 97 30 101 28 +4 
RBANS = Repeatable Battery for the Assessment of Neuropsychological Status Total Index Score; 
MMSE = Mini Mental State Examination; Change = Post RBANS Total Index - Pre RBANS Total 
Index 
*significant change based on reliable change index (1.96*Standard Error of Measurement)  
 
Visuospatial/Constructional Index, U = 45.5, z = -0.19, p = 0.86; Language Index, U = 
44, z = -0.30, p = 0.80; Attention Index, U = 50, z = 0.15, p = 0.91; Delayed Memory 
Index, U = 34.5, z = -1.00, p = 0.33). 
 Wilcoxon Signed Rank tests were used to compare pre and post-TAVI 
performance in participants with new ischemic lesions. The Wilcoxon Signed Rank tests 
results are summarized in Table 10. The Wilcoxon Signed Rank tests demonstrated no 
significant differences between pre and post-TAVI cognitive measures.  The Wilcoxon 
Signed Rank test revealed a significant difference between and pre and post-TAVI mean 
gradient scores.  
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Table 10 
 
Wilcoxon Signed Rank Tests results in participants (n = 6) with new 
ischemic lesions 
Variable z-score p 
MMSE 0.00 1.00 
RBANS Total Score -0.41 0.69 
RBANS  Immediate Memory Index 
 
-0.14 0.89 
RBANS Visuospatial/Constructional Index -1.47 0.14 
RBANS Language Index -0.42 0.67 
RBANS Attention Index 0.00 1.00 
RBANS Delayed Memory Index -0.67 0.50 
RBANS Fluency Subtest -0.63 0.53 
RBANS List Recall Subtest -0.54 0.59 
RBANS Figure Recall -0.42 0.67 
DSB 0.00 1.00 
Stroop Word-Color Test -0.27 0.79 
KCCQ -1.75 0.08 
GDS -0.41 0.68 
Mean Gradient -2.02 0.043* 
Stroop Word-Color = third trial of the Stroop Word-Color Test; KCCQ = Kansas City 
Cardiomyopathy Questionnaire  
* = p < 0.05 
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CHAPTER IV 
DISCUSSION 
The TAVI patient population is older adults (M = 79.04 years old, SD = 7.79) with 
multiple medical conditions (see Table 2). The patient population has high rates for 
chronic medical conditions (i.e., chronic kidney disease, chronic obstructive pulmonary 
disease, coronary artery disease, etc.) that potentially contribute to changes in functional 
abilities and cognitive functioning. Therefore, the TAVI population has unique cognitive 
concerns. The present study's sample had an education level slightly above high school 
(M = 12.51, SD = 3.75, range 6 to 20) and an estimated premorbid cognitive ability in the 
average range (WTAR Standard Score, M = 97.23, SD = 12.59). Despite estimated 
average cognitive functioning, when compared to similar aged adults at baseline, some 
areas of cognitive functioning fell into low average range (Standard Score (SS) = 80-89): 
RBANS Total Index, Immediate Memory Index, Attention Index, Delayed Index 
Standard Scores. On the RBANS, language and visuospatial/constructional abilities were 
within the average range (SS = 90-109). Mild decline in attention and verbal memory are 
consistent with the cognitive sequalae of cardiovascular diseases, and consistent with 
previous research of pre-cardiac surgery patients (Silbert, Scott, Evered, Lewis, Maruff, 
2007).  
 In TAVI patients, the overall cognitive functioning appears stable one month 
following the procedure. Of the 23 cognitive measures compared (pre versus post-TAVI) 
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only 4 showed significant change (three measures improved and one declined). The 
observed significant changes are likely not clinically significant (see below), and without 
a control group comparison we cannot conclude that these changes exist beyond those 
expected through practice effects.  There were statistically significant improvements in 
the RBANS Language Index, the RBANS Fluency subtest, and the RBANS Figure Recall 
subtest. The mild improvements are consistent with previous studies; Ghanem and 
colleages (2013) also found a significant improvement on the RBANS Language Index at 
a 3-month post-TAVI evaluation. At the subtest level, a significant improvement was 
observed on the Fluency subtest of the Language Index. The Picture Naming subtest was 
not analyzed because it failed normality assumptions. Ghanem et al. (2013) did not 
analyze results at the subtest level, so it is unknown if an increase in Fluency was also 
consistent with their results. Letter fluency was also examined in the present study, which 
requires participants to give words beginning with a certain letter rather than words 
within a semantic category (as in the RBANS). When participants were given the 
phonemic cues (Letter Fluency) no significant improvement was observed. There are 
several reasons why RBANS Fluency and Letter Fluency produced different results. 
First, RBANS Fluency is based on one trial while Letter Fluency scores are comprised of 
three trials. Second, the RBANS Fluency was introduced before Letter Fluency, so task 
familiarity and practice effects may have influenced Letter Fluency performance. Third, 
semantic and phonemic fluency tasks likely engage different brain areas, with phonemic 
fluency being more sensitive to frontal lobe dysfunction (Strauss, Sherman, & Spreen, 
2006). Although Fluency loads the Language Index on the RBANS, semantic fluency is 
often considered an executive or frontal lobe function (Butler, Rorsman, Hill & Tuma, 
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1993). Other measures of executive function did not significantly change (Trailmaking B, 
VSAT, Digit Span Backward). However, Stroop Word-Color Interference (i.e., trial 
three) was near significance (p = 0.06). The improvement on RBANS Fluency exists 
without generalized executive function improvement.  
 The significant improvement of RBANS Figure Recall and significant decline on 
RBANS Delayed List Recall may have nullified any changes in overall memory 
performance. The present study's results are consistent with Ghanem and colleagues 
(2013) who also did not find a significant change in delayed memory. However, Alassar 
and colleagues (2015) did find an improvement in memory performance using a complex 
figure test and auditory verbal learning test. The complex figure and auditory verbal 
learning test may be more sensitive to changes in delayed memory than the RBANS. The 
improvement in visual memory (Figure Recall) and decline in verbal memory (List 
Recall) could be unique to our sample or could be representative of trends in the 
population. Future research examining memory performance in the TAVI population may 
benefit from differentiating language and visual memory tasks. 
 The present study failed to find significant change in mental control and 
processing speed, as predicted. Knipp and colleagues (2013) found significant 
improvement in TA-TAVI participants on MMSE and Digit Span Backwards between 
the postoperative evaluation and at the three month follow-up. The improvement at three 
months was not significantly different from baseline (Knipp et al., 2013). The present 
study included other measures of mental control (e.g., VSAT, Trailmaking Test, Stroop 
Word-Color) with Digit Span Backward in an effort to observe nuanced changes in 
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complex attention. The lack of significance at follow-up supports that previously 
observed changes in mental control are transient in nature. 
 No significant changes were found in processing speed measures (RBANS 
Coding, Stroop Word, Stroop Color, Trailmaking Test A). Prior to the present study's 
outset, no previous TAVI cognitive studies included measures of processing speed. As 
processing speed influences performance across cognitive measures, it was important to 
rule out changes in processing speed as the underlying mechanism for changes in 
complex mental processes. Specifically, given the time limits in fluency tests, improved 
processing speed would help account for significant improvement in RBANS Fluency. 
The present study's results are consistent with a recent publication in TAVI cognitive 
research: Alassar et al. (2015) also failed to find significant improvement in processing 
speed following the TAVI and in AVR patients. 
 Ghanem and colleagues (2013) found a significant improvement on the RBANS 
Immediate Memory Index three days postoperative. The improvement did not persist at 
the three-month follow-up (Ghanem et al., 2013). The lack of significance on the RBANS 
Immediate Memory Index supports the transient nature of improvements found by 
Ghanem et al. (2013). 
 Despite statistically significant changes, the clinical relevance is important to 
examine. Using the reliable change index (Jacobson & Truax, 1991), two scores are 
determined as significantly different when obtaining the scores by chance (based on a 
measure's error) has a less than 5% probability. Reliable change index scores were 
calculated for RBANS Language Index, RBANS Fluency, and RBANS Figure Recall 
using the following formula: RCI = 1.96(Standard Error of Measurement). The RCI's 
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were calculated using standard error of measurement scores for ages 80-89 (Randolf, 
2012), because the age group was most representative of the present study's sample. An 
RCI was not calculated for List Recall because Randolf (2012) did not provide a standard 
error of measurement. No observed changes in RBANS met criteria for a reliable change. 
The difference in pre-post RBANS Language Index was 4.08 points, which fell below the 
RCI threshold (RCI = 12.11). On average, the difference in RBANS Fluency was 1.51 
words, which fell below the RCI threshold of 4.08. The participants mean score for 
Figure Recall was 1.34 points higher after the TAVI, which falls below the RCI threshold 
for significant change (RCI = 3.94). Failing to exceed the RCI indicates that the 
difference between pre and posttest scores could not be reliably measured based on the 
psychometric properties of the RBANS index and subtest scores. The group difference 
scores (i.e., RBANS Language Index, Fluency, and Figure Recall) are statistically 
significant, but the ability to consistently measure these changes on an individual basis 
are unlikely.  
 The lack of significant cognitive changes is still clinically relevant. Postoperative 
cognitive decline (POCD) is a common concern, especially following cardiac surgery. 
POCD prevalence rates have varied from 10-60% of patients following CABG, and rates 
are typically higher following valve surgery due to increased micro-emboli (Lombard & 
Mathew, 2010). The high ischemic injury rates in previous TAVI studies (Arnold et al., 
2010; Rodes-Cabau et al, 2011; Kahlert et al., 2010; Samim et al., 2015) have brought 
cognitive implications and functional changes to the forefront of TAVI-related outcome 
research.  
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 Previous studies have shown ischemic injury rates post-TAVI in as high as 90% 
of patients (Samim et al., 2015). However, high incidence of ischemia may have been 
inflated by follow-up neuroimaging timing with higher rates within one week post 
procedure. Alassar and colleagues (2015) found that approximately 1/3 of patients with 
initial ischemia resolved at 3 months. Similarly, Kahlert and colleagues (2010) found 
80% of acute restricted diffusion detected by DW-MRI following the procedure resolved 
at 3 months. The present study found 27% (6 of 22) had ischemic lesions that persisted at 
one month. The lesions were generally small and dispersed throughout the brain. No 
participants were diagnosed with a stroke following the TAVI; therefore, all lesions were 
assumed as clinically silent. However, two participants in the study may have had 
neurological changes, which suggests clinically apparent stroke or transient ischemic 
attack (TIA). One participant excluded from the MRI protocol, reported transient 
unilateral hearing loss that resolved at one month. Another participant that withdrew from 
the study before the one month follow-up had a major stroke: occlusion of the middle 
cerebral artery (MCA). No other neurological symptoms were reported; however, a 
neurological examination was not included in the present study.  
 Of the six participants with new lesions, only one participant evidenced a 
clinically significant decline in overall cognitive function (RBANS Total difference = 23, 
RBANS Total score RCI = 7.19). Based on Ghanem and colleagues' (2013) results, group 
differences in cognitive performance between participants that experienced new lesions 
compared to those without were not anticipated. No significant differences were observed 
between persons with lesions and those without, supporting the notion that the majority 
of ischemic lesions following TAVI are likely clinically silent. However, only 6 
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participants evidenced new ischemia, which likely resulted in insufficient power to detect 
even medium to large effect sizes.  
 Numerous factors potentially influence cognitive function following cardiac 
procedures beyond direct cerebral injury. The change in RBANS Total score from pre to 
post-TAVI was not significantly predicted using the independent variables procedural 
length, STS score, and postoperative mean gradient. Procedure length is an indirect 
measure of surgery complexity and previous research indicated longer procedure length 
in patients with postoperative cognitive decline (Ghanem, 2013). The STS score, a 
routinely used algorithm to predict mortality, represents a summation of medical 
conditions and cardiac risk factors. Mean gradient is used to grade the severity of aortic 
stenosis (Otto, 2006), and a lower post-TAVI mean gradient represents improved 
functioning and blood flow through the aortic valve. Procedure length, mean gradient, 
and STS were not predictive of changes in RBANS Total score. Similarly, procedure 
length, mean gradient, and STS score failed to significantly predict changes in RBANS 
Language Index, RBANS Fluency subtest, RBANS List Recall, and RBANS Figure 
Recall. 
 Quality of life improves following the TAVI procedure. A significant 
improvement was observed in the KCCQ, which is consistent with previous TAVI 
studies. The KCCQ includes aspects of cardiac symptom severity and activity level. 
Improved quality of life may be related to reduced aortic stenosis symptoms (e.g., angina, 
shortness of breath, etc.) resulting from successful aortic valve implantation. In addition 
to improved KCCQ scores, participants had significantly improved GDS scores. The 
improved mood can be attributed to multiple factors. First, as evidenced in the KCCQ, 
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reduced symptom severity and improved activity may improve mood. Second, the pre-
TAVI GDS was administered a day before the procedure and temporary distress may 
have inflated baseline GDS scores. Some GDS questions relate to future worries (e.g., 
"Are you afraid that something bad is going to happen to you?") and a major medical 
procedure may induce distress. Third, a complex relationship exists between 
cardiovascular disease, cardiac surgeries, and depression. Depression can increase 
incidence for cardiovascular disease (Lett et al., 2004) and stroke (Pan et al., 2011). 
Depression with onset later in life may result from the interrelationships between 
cardiovascular disease, cerebral injury, and cognitive function (Taylor, Aizenstein, & 
Alexopoulos, 2013). White matter hyperintensities (i.e., bright areas on MRIs in the 
white matter tracts, as opposed to the cortical gray matter, resulting from neuronal 
damage, such as ischemia) are associated with cognitive deficits and onset of late-life 
depression (Taylor, Aizenstein, & Alexopoulos, 2013). As the present study's 
participants' had mild cognitive decline, as evidenced by actual performance falling 
below predicted (WTAR), and multiple vascular risk factors (e.g., coronary artery 
disease, hypertension, hyperlipidemia, etc.) a "vascular depression" may have resulted. 
Increased perfusion to the brain from improved aortic valve function potentially 
influences depressive symptoms. However, future research is needed examining 
depression in TAVI patients before making any conclusions. 
 Prior to the TAVI, seven participants met criteria for frailty and two met criteria 
at follow-up. The low prevalence of frailty within the sample limited statistical analyses. 
However, patterns in the characteristics of frail participants may inform future research. 
The pre-TAVI Total RBANS score for frail participants fell below the overall sample's 
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mean RBANS Total score, and the GDS scores appear higher. In future research, use of 
cognitive measures and mood symptoms may help further define frailty. In the present 
study, two questions from the CES-D were used in meeting criteria for frailty. A 
relationship between endorsement on the CES-D questions and higher GDS scores is 
anticipated, as both are measures of depression. Lower Total RBANS scores in frail 
individuals could be bidirectional. Frail individuals may have a lowered ability to engage 
in cognitively demanding tasks. Additionally, cognitive decline may be related to 
increased incidence of frailty. Examining cognitive changes in frail TAVI patients in 
future research could help further our understanding of the frailty construct and how frail 
individuals differ from non-frail patients.  
Limitations 
 A limitation in the present study is high family-wise error rate. Controlling for 
family-wise error using Bonferroni or a less conservative Holm step-down procedure for 
the dependent t-tests results in only two significant differences (KCCQ, p < .001; 
RBANS List Recall, p = 0.001). Given the potential for Type I errors, replication of the 
study's results are needed. 
 Another limitation is low n for both ischemic lesions and frailty. Low n prohibited 
using MRI data in regression analyses. Additionally, nonparametric analyses, the Mann-
Whitney U, were used to compare group differences using the neuroimaging data. 
Nonparametric tests tend to have lower power than parametric (Howell, 2010). Using 
parametric analyses, a larger n would increase the likelihood of meeting a test's 
assumptions (e.g., normal distribution). 
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 Another limitation is the complex medical conditions present in most TAVI 
candidates. Multiple chronic medical conditions make distinguishing and isolating 
relevant variables difficult. Future studies will likely have similar sample characteristics 
because the TAVI remains an alternative procedure for high-risk patients; however, 
healthy control group comparisons are needed in future research. 
Future Directions 
The risk of cerebral injury following TAVI remains a major concern in the TAVI 
community, because in recent years many studies published support higher ischemic 
injury rates in TAVI patients (Kahlert et al., 2010; Samim et al., 2015). However, a link 
between silent ischemia and decreased cognitive or functional ability remains 
unsubstantiated (Alassar et al., 2015; Ghanem et al., 2013). Randomized controlled trials 
are needed to understand the relationship between TAVI and cognitive performance.  
 Additionally, using DW-MRI may not provide the best measure of neuronal 
injury. Many ischemic lesions resolve on the imaging (Kahert et al., 2010; Alassar et al., 
2015), suggesting that higher rates of ischemia may not result in permanent neuronal 
damage. Additionally, baseline MRI brain classification may predict cognitive decline 
better than postoperative ischemia lesions (Lund et al., 2005). In the present study, no 
significant differences were found between those with new lesions and those without on 
cognitive measures using Mann-Whitney U, and that Ghanem and colleagues (2013) 
failed to find differences between the groups. Therefore, future research may find other 
markers of brain health more useful than new ischemic lesions.  
 Since the present study found a significant improvement in mood, further research 
is needed to explain the change. Specifically, are external factors (i.e., improved quality 
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of life, decreased effects of aortic stenosis in daily life, postoperative decreased stress 
after surviving a cardiac procedure etc.) or physiological changes (i.e., increased 
perfusion to the brain) accounting for the observed mood changes?  
 Finally, future research may extend the patient selection criteria beyond the 
current population (i.e., ineligible for AVR). Given the generally stable cognitive 
performance following TAVI (present study; Alassar et al., 2015; Ghenam et al., 2013), 
patient's with pre-existing cognitive or neurological disorders that otherwise qualify for 
AVR, may have better long term cognitive results with an alternative TAVI procedure. 
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